| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.804 | 0.004 | 0.812 | Spasmolytic | 0.812 0.004 DBMET03338 0.337 0.057 DBMET01477 0.698 0.006 DB00122 | DBMET03338 | |
| 0.722 | 0.007 | 0.79 | Cholesterol antagonist | 0.79 0.004 DBMET03338 0.674 0.01 DBMET01477 0.711 0.007 DB00122 | DBMET03338 | |
| 0.675 | 0.008 | 0.721 | Vasodilator, peripheral | 0.721 0.005 DBMET03338 0.621 0.014 DBMET01477 0.61 0.015 DB00122 | DBMET03338 | |
| 0.661 | 0.005 | 0.711 | Psychostimulant | 0.711 0.004 DBMET03338 0.426 0.019 DBMET01477 0.497 0.011 DB00122 | DBMET03338 | |
| 0.625 | 0.005 | 0.65 | Platelet aggregation inhibitor | 0.65 0.005 DBMET03338 0.649 0.005 DBMET01477 0.454 0.013 DB00122 | DBMET03338 | |
| 0.599 | 0.016 | 0.683 | Antithrombotic | 0.683 0.009 DBMET03338 0.547 0.023 DBMET01477 0.503 0.029 DB00122 | DBMET03338 | |
| 0.569 | 0.005 | 0.615 | Cholinergic | 0.334 0.015 DBMET03338 0.615 0.005 DB00122 | DB00122 | |
| 0.562 | 0.008 | 0.562 | Vasodilator | 0.531 0.01 DBMET03338 0.385 0.026 DBMET01477 0.536 0.009 DB00122 | ||
| 0.559 | 0.01 | 0.559 | Vasodilator, coronary | 0.545 0.011 DBMET03338 0.374 0.045 DBMET01477 0.551 0.01 DB00122 | ||
| 0.554 | 0.004 | 0.631 | Interleukin 6 antagonist | 0.492 0.005 DBMET03338 0.239 0.025 DBMET01477 0.631 0.004 DB00122 | DB00122 | |
| 0.531 | 0.005 | 0.614 | Phospholipase C inhibitor | 0.614 0.004 DBMET03338 0.487 0.006 DBMET01477 0.538 0.005 DB00122 | DBMET03338 | |
| 0.545 | 0.027 | 0.73 | Aldehyde oxidase inhibitor | 0.597 0.019 DBMET03338 0.73 0.006 DBMET01477 0.649 0.013 DB00122 | DBMET01477 | |
| 0.497 | 0.004 | 0.497 | Anesthetic local | 0.372 0.008 DBMET03338 0.112 0.073 DBMET01477 0.421 0.006 DB00122 | ||
| 0.487 | 0.015 | 0.487 | DNA damaging | 0.467 0.017 DBMET03338 0.338 0.044 DBMET01477 0.376 0.034 DB00122 | ||
| 0.46 | 0.018 | 0.864 | Platelet antagonist | 0.608 0.006 DBMET03338 0.864 0.004 DBMET01477 0.171 0.125 DB00122 | DBMET01477 | |
| 0.454 | 0.04 | 0.591 | GABA C receptor rho-3 antagonist | 0.332 0.096 DBMET03338 0.591 0.008 DBMET01477 0.464 0.037 DB00122 | DBMET01477 | |
| 0.448 | 0.051 | 0.617 | Histamine release inhibitor | 0.501 0.028 DBMET03338 0.617 0.009 DBMET01477 0.354 0.098 DB00122 | DBMET01477 | |
| 0.405 | 0.008 | 0.405 | Cholinergic antagonist | 0.317 0.013 DBMET03338 0.323 0.012 DB00122 | ||
| 0.415 | 0.019 | 0.525 | Angiogenesis stimulant | 0.449 0.015 DBMET03338 0.525 0.01 DBMET01477 0.409 0.02 DB00122 | DBMET01477 | |
| 0.389 | 0.005 | 0.389 | Acetylcholine nicotinic antagonist | 0.287 0.007 DBMET03338 0.077 0.057 DBMET01477 0.227 0.01 DB00122 | ||
| 0.422 | 0.043 | 0.472 | Immunostimulant | 0.472 0.033 DBMET03338 0.402 0.049 DBMET01477 0.378 0.056 DB00122 | DBMET03338 | |
| 0.393 | 0.017 | 0.512 | Anesthetic general | 0.442 0.012 DBMET03338 0.512 0.007 DBMET01477 0.337 0.026 DB00122 | DBMET01477 | |
| 0.382 | 0.008 | 0.382 | Acetylcholine antagonist | 0.294 0.014 DBMET03338 0.312 0.013 DB00122 | ||
| 0.376 | 0.011 | 0.651 | Tyrosine 3 hydroxylase inhibitor | 0.446 0.005 DBMET03338 0.651 0.003 DBMET01477 0.318 0.025 DB00122 | DBMET01477 | |
| 0.388 | 0.027 | 0.524 | Hypolipemic | 0.436 0.019 DBMET03338 0.524 0.011 DBMET01477 0.304 0.048 DB00122 | DBMET01477 | |
| 0.374 | 0.016 | 0.376 | Hepatoprotectant | 0.376 0.016 DBMET03338 0.347 0.019 DBMET01477 0.344 0.02 DB00122 | DBMET03338 | |
| 0.367 | 0.008 | 0.379 | Acetylcholinesterase inhibitor | 0.212 0.03 DBMET03338 0.379 0.008 DB00122 | DB00122 | |
| 0.449 | 0.092 | 0.449 | Apoptosis agonist | 0.401 0.113 DBMET03338 0.363 0.132 DBMET01477 0.361 0.133 DB00122 | ||
| 0.357 | 0.003 | 0.357 | Acetylcholine release stimulant | 0.214 0.004 DBMET03338 0.143 0.021 DBMET01477 0.182 0.005 DB00122 | ||
| 0.439 | 0.089 | 0.736 | Caspase 9 stimulant | 0.444 0.086 DBMET03338 0.736 0.02 DBMET01477 0.511 0.056 DB00122 | DBMET01477 | |
| 0.353 | 0.008 | 0.442 | Phospholipase A2 inhibitor | 0.442 0.004 DBMET03338 0.302 0.013 DBMET01477 0.266 0.02 DB00122 | DBMET03338 | |
| 0.4 | 0.06 | 0.535 | Toll-Like receptor agonist | 0.473 0.037 DBMET03338 0.535 0.026 DBMET01477 0.427 0.05 DB00122 | DBMET01477 | |
| 0.349 | 0.01 | 0.377 | Alkylator | 0.377 0.009 DBMET03338 0.241 0.018 DBMET01477 0.305 0.012 DB00122 | DBMET03338 | |
| 0.371 | 0.034 | 0.427 | Cardiotonic | 0.324 0.047 DBMET03338 0.427 0.024 DB00122 | DB00122 | |
| 0.333 | 0.008 | 0.858 | GABA C receptor agonist | 0.512 0.004 DBMET03338 0.858 0.001 DBMET01477 0.363 0.006 DB00122 | DBMET01477 | |
| 0.324 | 0.011 | 0.339 | Acetylcholine M1 receptor antagonist | 0.289 0.016 DBMET03338 0.144 0.08 DBMET01477 0.339 0.009 DB00122 | DB00122 | |
| 0.315 | 0.004 | 0.358 | Vanilloid 1 agonist | 0.358 0.004 DBMET03338 0.207 0.01 DBMET01477 0.235 0.006 DB00122 | DBMET03338 | |
| 0.323 | 0.016 | 0.406 | Cytidine deaminase inhibitor | 0.253 0.029 DBMET03338 0.129 0.092 DBMET01477 0.406 0.01 DB00122 | DB00122 | |
| 0.323 | 0.019 | 0.398 | Gastrin inhibitor | 0.355 0.009 DBMET03338 0.398 0.005 DBMET01477 0.275 0.053 DB00122 | DBMET01477 | |
| 0.309 | 0.008 | 0.309 | Acetylcholine muscarinic antagonist | 0.248 0.015 DBMET03338 0.099 0.092 DBMET01477 0.296 0.009 DB00122 | ||
| 0.352 | 0.055 | 0.657 | Apoptosis antagonist | 0.469 0.024 DBMET03338 0.657 0.005 DBMET01477 0.256 0.122 DB00122 | DBMET01477 | |
| 0.35 | 0.057 | 0.547 | 5 Hydroxytryptamine release stimulant | 0.234 0.097 DBMET03338 0.547 0.02 DBMET01477 0.402 0.045 DB00122 | DBMET01477 | |
| 0.295 | 0.002 | 0.369 | Acetylcholine M3 receptor agonist | 0.235 0.003 DBMET03338 0.369 0.002 DB00122 | DB00122 | |
| 0.332 | 0.042 | 0.531 | Interleukin antagonist | 0.401 0.031 DBMET03338 0.531 0.017 DBMET01477 0.194 0.088 DB00122 | DBMET01477 | |
| 0.302 | 0.016 | 0.809 | Alpha-N-acetylglucosaminidase inhibitor | 0.385 0.01 DBMET03338 0.809 0.002 DBMET01477 0.566 0.004 DB00122 | DBMET01477 | |
| 0.299 | 0.014 | 0.338 | Adenylate cyclase inhibitor | 0.338 0.01 DBMET03338 0.236 0.021 DBMET01477 0.328 0.011 DB00122 | DBMET03338 | |
| 0.356 | 0.079 | 0.508 | Toll-Like receptor 7 agonist | 0.439 0.046 DBMET03338 0.508 0.03 DBMET01477 0.419 0.053 DB00122 | DBMET01477 | |
| 0.285 | 0.007 | 0.412 | Telomerase inhibitor | 0.18 0.016 DBMET03338 0.412 0.004 DB00122 | DB00122 | |
| 0.295 | 0.022 | 0.41 | Lipocortins synthesis antagonist | 0.326 0.017 DBMET03338 0.41 0.008 DBMET01477 0.141 0.119 DB00122 | DBMET01477 | |
| 0.365 | 0.094 | 0.421 | Antibacterial | 0.381 0.086 DBMET03338 0.36 0.096 DBMET01477 0.421 0.068 DB00122 | DB00122 | |
| 0.259 | 0.004 | 0.278 | Sphingomyelinase inhibitor | 0.233 0.005 DBMET03338 0.133 0.033 DBMET01477 0.278 0.004 DB00122 | DB00122 | |
| 0.3 | 0.045 | 0.561 | 5 Hydroxytryptamine uptake stimulant | 0.305 0.042 DBMET03338 0.561 0.003 DBMET01477 0.279 0.057 DB00122 | DBMET01477 | |
| 0.324 | 0.07 | 0.448 | Immunomodulator | 0.368 0.054 DBMET03338 0.448 0.032 DBMET01477 0.387 0.048 DB00122 | DBMET01477 | |
| 0.255 | 0.003 | 0.34 | Acetylcholine M2 receptor agonist | 0.171 0.004 DBMET03338 0.34 0.002 DB00122 | DB00122 | |
| 0.266 | 0.016 | 0.266 | Interleukin 1 antagonist | 0.235 0.022 DBMET03338 0.116 0.095 DBMET01477 0.235 0.022 DB00122 | ||
| 0.268 | 0.02 | 0.269 | Antipruritic | 0.269 0.02 DBMET03338 0.218 0.038 DBMET01477 0.234 0.03 DB00122 | DBMET03338 | |
| 0.354 | 0.111 | 0.583 | 5 Hydroxytryptamine release inhibitor | 0.341 0.123 DBMET03338 0.583 0.013 DBMET01477 0.403 0.076 DB00122 | DBMET01477 | |
| 0.299 | 0.059 | 0.408 | Insulysin inhibitor | 0.336 0.04 DBMET03338 0.408 0.021 DBMET01477 0.24 0.106 DB00122 | DBMET01477 | |
| 0.264 | 0.026 | 0.341 | Growth factor agonist | 0.223 0.045 DBMET03338 0.341 0.009 DB00122 | DB00122 | |
| 0.242 | 0.009 | 0.272 | Potassium channel (Ca-activated) activator | 0.272 0.006 DBMET03338 0.191 0.016 DBMET01477 0.247 0.008 DB00122 | DBMET03338 | |
| 0.236 | 0.005 | 0.253 | Interferon agonist | 0.253 0.004 DBMET03338 0.17 0.008 DBMET01477 0.249 0.004 DB00122 | DBMET03338 | |
| 0.378 | 0.153 | 0.589 | Antiinflammatory | 0.441 0.115 DBMET03338 0.589 0.057 DBMET01477 0.274 0.241 DB00122 | DBMET01477 | |
| 0.241 | 0.018 | 0.288 | Cell wall synthesis inhibitor | 0.271 0.013 DBMET03338 0.277 0.012 DBMET01477 0.288 0.01 DB00122 | DB00122 | |
| 0.23 | 0.008 | 0.257 | Interleukin 8 antagonist | 0.257 0.005 DBMET03338 0.2 0.013 DBMET01477 0.23 0.008 DB00122 | DBMET03338 | |
| 0.227 | 0.005 | 0.245 | Vanilloid agonist | 0.186 0.008 DBMET03338 0.123 0.017 DBMET01477 0.245 0.005 DB00122 | DB00122 | |
| 0.232 | 0.011 | 0.259 | Arachidonic acid antagonist | 0.24 0.008 DBMET03338 0.259 0.004 DBMET01477 0.209 0.025 DB00122 | DBMET01477 | |
| 0.235 | 0.014 | 0.235 | Antibacterial (Helicobacter pylori) | 0.217 0.018 DBMET03338 0.158 0.04 DBMET01477 0.165 0.036 DB00122 | ||
| 0.227 | 0.012 | 0.425 | Adenylate kinase inhibitor | 0.306 0.007 DBMET03338 0.425 0.003 DBMET01477 0.215 0.013 DB00122 | DBMET01477 | |
| 0.246 | 0.032 | 0.246 | Tumour necrosis factor antagonist | 0.185 0.063 DBMET03338 0.165 0.082 DBMET01477 0.163 0.085 DB00122 | ||
| 0.27 | 0.055 | 0.434 | DNA synthesis inhibitor | 0.318 0.038 DBMET03338 0.434 0.018 DBMET01477 0.326 0.036 DB00122 | DBMET01477 | |
| 0.263 | 0.052 | 0.273 | Anticonvulsant | 0.273 0.048 DBMET03338 0.232 0.064 DBMET01477 0.164 0.113 DB00122 | DBMET03338 | |
| 0.219 | 0.009 | 0.334 | Photosensitizer | 0.265 0.005 DBMET03338 0.334 0.004 DBMET01477 0.136 0.041 DB00122 | DBMET01477 | |
| 0.212 | 0.009 | 0.268 | Adenylate cyclase stimulant | 0.232 0.005 DBMET03338 0.268 0.004 DBMET01477 0.205 0.011 DB00122 | DBMET01477 | |
| 0.209 | 0.009 | 0.641 | Glutamate dehydrogenase inhibitor | 0.36 0.004 DBMET03338 0.641 0.002 DBMET01477 0.143 0.017 DB00122 | DBMET01477 | |
| 0.216 | 0.022 | 0.216 | Platelet activating factor antagonist | 0.096 0.082 DBMET03338 0.209 0.024 DB00122 | ||
| 0.224 | 0.033 | 0.704 | Succinate dehydrogenase inhibitor | 0.297 0.011 DBMET03338 0.704 0.002 DBMET01477 0.28 0.014 DB00122 | DBMET01477 | |
| 0.202 | 0.014 | 0.202 | Acetylcholine agonist | 0.102 0.045 DBMET03338 0.187 0.016 DB00122 | ||
| 0.264 | 0.077 | 0.387 | Antioxidant | 0.3 0.062 DBMET03338 0.387 0.037 DBMET01477 0.22 0.101 DB00122 | DBMET01477 | |
| 0.238 | 0.052 | 0.341 | DNA methyltransferase I inhibitor | 0.289 0.03 DBMET03338 0.341 0.015 DBMET01477 0.251 0.047 DB00122 | DBMET01477 | |
| 0.207 | 0.02 | 0.207 | Butyrylcholinesterase inhibitor | 0.084 0.077 DBMET03338 0.179 0.025 DB00122 | ||
| 0.311 | 0.124 | 0.313 | 15-Lipoxygenase inhibitor | 0.298 0.133 DBMET03338 0.279 0.144 DBMET01477 0.313 0.123 DB00122 | DB00122 | |
| 0.215 | 0.029 | 0.262 | Neurotensin receptor agonist | 0.241 0.023 DBMET03338 0.262 0.019 DBMET01477 0.203 0.033 DB00122 | DBMET01477 | |
| 0.191 | 0.007 | 0.302 | Potassium channel large-conductance Ca-activated activator | 0.189 0.007 DBMET03338 0.133 0.014 DBMET01477 0.302 0.004 DB00122 | DB00122 | |
| 0.188 | 0.007 | 0.188 | Acetylcholine muscarinic agonist | 0.073 0.025 DBMET03338 0.18 0.008 DB00122 | ||
| 0.252 | 0.077 | 0.479 | Interleukin agonist | 0.299 0.048 DBMET03338 0.479 0.01 DBMET01477 0.239 0.087 DB00122 | DBMET01477 | |
| 0.215 | 0.041 | 0.241 | 5 Hydroxytryptamine 3E antagonist | 0.167 0.146 DBMET03338 0.204 0.055 DBMET01477 0.241 0.02 DB00122 | DB00122 | |
| 0.281 | 0.111 | 0.396 | Calcium channel activator | 0.233 0.168 DBMET03338 0.396 0.026 DBMET01477 0.269 0.125 DB00122 | DBMET01477 | |
| 0.22 | 0.053 | 0.22 | P-glycoprotein inhibitor | 0.189 0.072 DBMET03338 0.159 0.104 DBMET01477 0.172 0.088 DB00122 | ||
| 0.333 | 0.17 | 0.469 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.469 0.05 DBMET01477 0.421 0.083 DB00122 | DBMET01477 | |
| 0.244 | 0.08 | 0.59 | Hypoglycemic | 0.362 0.035 DBMET03338 0.59 0.009 DBMET01477 0.184 0.129 DB00122 | DBMET01477 | |
| 0.218 | 0.057 | 0.321 | Insulin sensitizer | 0.262 0.028 DBMET03338 0.321 0.012 DBMET01477 0.191 0.083 DB00122 | DBMET01477 | |
| 0.219 | 0.058 | 0.358 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.23 0.052 DBMET03338 0.358 0.011 DBMET01477 0.263 0.037 DB00122 | DBMET01477 | |
| 0.172 | 0.012 | 0.22 | Ca2+-transporting ATPase inhibitor | 0.167 0.015 DBMET03338 0.22 0.002 DBMET01477 0.175 0.01 DB00122 | DBMET01477 | |
| 0.174 | 0.014 | 0.48 | Phosphofructokinase-1 inhibitor | 0.249 0.008 DBMET03338 0.48 0.002 DBMET01477 0.198 0.011 DB00122 | DBMET01477 | |
| 0.163 | 0.004 | 0.163 | Acetylcholine M5 receptor agonist | 0.116 0.012 DBMET03338 0.062 0.053 DBMET01477 0.146 0.005 DB00122 | ||
| 0.184 | 0.025 | 0.219 | Cyclooxygenase 3 inhibitor | 0.176 0.029 DBMET03338 0.219 0.013 DBMET01477 0.114 0.084 DB00122 | DBMET01477 | |
| 0.168 | 0.01 | 0.174 | Anabolic | 0.167 0.01 DBMET03338 0.174 0.008 DBMET01477 0.163 0.012 DB00122 | DBMET01477 | |
| 0.172 | 0.015 | 0.625 | Triose-phosphate isomerase inhibitor | 0.275 0.005 DBMET03338 0.625 0.002 DBMET01477 0.248 0.007 DB00122 | DBMET01477 | |
| 0.173 | 0.018 | 0.189 | TRPA1 agonist | 0.167 0.021 DBMET03338 0.189 0.013 DBMET01477 0.158 0.026 DB00122 | DBMET01477 | |
| 0.167 | 0.013 | 0.167 | Acetylcholine nicotinic agonist | 0.1 0.037 DBMET03338 0.143 0.019 DB00122 | ||
| 0.213 | 0.062 | 0.354 | Non-steroidal antiinflammatory agent | 0.258 0.04 DBMET03338 0.354 0.019 DBMET01477 | DBMET01477 | |
| 0.227 | 0.076 | 0.302 | Cyclic AMP phosphodiesterase inhibitor | 0.197 0.096 DBMET03338 0.302 0.041 DBMET01477 0.202 0.092 DB00122 | DBMET01477 | |
| 0.183 | 0.032 | 0.265 | Toll-Like receptor 2 antagonist | 0.209 0.02 DBMET03338 0.265 0.007 DBMET01477 0.14 0.06 DB00122 | DBMET01477 | |
| 0.185 | 0.038 | 0.27 | GABA C receptor rho-2 antagonist | 0.151 0.073 DBMET03338 0.27 0.008 DBMET01477 0.21 0.024 DB00122 | DBMET01477 | |
| 0.156 | 0.009 | 0.156 | Acetylcholine M4 receptor antagonist | 0.096 0.032 DBMET03338 0.139 0.012 DB00122 | ||
| 0.164 | 0.018 | 0.33 | Folate antagonist | 0.213 0.008 DBMET03338 0.33 0.003 DBMET01477 | DBMET01477 | |
| 0.215 | 0.07 | 0.337 | DNA methylase inhibitor | 0.259 0.043 DBMET03338 0.337 0.019 DBMET01477 0.232 0.059 DB00122 | DBMET01477 | |
| 0.176 | 0.031 | 0.197 | Cathepsin H inhibitor | 0.162 0.038 DBMET03338 0.197 0.023 DBMET01477 0.171 0.033 DB00122 | DBMET01477 | |
| 0.218 | 0.076 | 0.367 | RNA-directed DNA polymerase inhibitor | 0.204 0.094 DBMET03338 0.367 0.022 DBMET01477 0.221 0.073 DB00122 | DBMET01477 | |
| 0.15 | 0.011 | 0.561 | Carbamoyl phosphate synthetase inhibitor | 0.227 0.006 DBMET03338 0.561 0.002 DBMET01477 0.177 0.009 DB00122 | DBMET01477 | |
| 0.162 | 0.023 | 0.411 | Catalase inhibitor | 0.233 0.01 DBMET03338 0.411 0.004 DBMET01477 0.134 0.03 DB00122 | DBMET01477 | |
| 0.171 | 0.036 | 0.221 | Nav1.3 sodium channel blocker | 0.128 0.065 DBMET03338 0.221 0.019 DB00122 | DB00122 | |
| 0.139 | 0.005 | 0.15 | Estrogen-related receptor beta agonist | 0.132 0.006 DBMET03338 0.15 0.004 DBMET01477 0.135 0.005 DB00122 | DBMET01477 | |
| 0.165 | 0.032 | 0.28 | Aminopeptidase B inhibitor | 0.2 0.021 DBMET03338 0.28 0.01 DBMET01477 0.167 0.031 DB00122 | DBMET01477 | |
| 0.168 | 0.038 | 0.413 | Aldehyde dehydrogenase inhibitor | 0.228 0.022 DBMET03338 0.413 0.005 DBMET01477 0.154 0.045 DB00122 | DBMET01477 | |
| 0.138 | 0.01 | 0.239 | Acyl-CoA dehydrogenase inhibitor | 0.153 0.009 DBMET03338 0.239 0.003 DBMET01477 0.184 0.006 DB00122 | DBMET01477 | |
| 0.156 | 0.029 | 0.273 | Mucolytic | 0.197 0.014 DBMET03338 0.273 0.005 DBMET01477 0.155 0.03 DB00122 | DBMET01477 | |
| 0.14 | 0.013 | 0.152 | Acetylcholine M2 receptor antagonist | 0.079 0.03 DBMET03338 0.152 0.011 DB00122 | DB00122 | |
| 0.177 | 0.051 | 0.337 | Protein kinase stimulant | 0.204 0.04 DBMET03338 0.337 0.013 DBMET01477 0.127 0.086 DB00122 | DBMET01477 | |
| 0.13 | 0.005 | 0.142 | Phospholipase D inhibitor | 0.134 0.004 DBMET03338 0.139 0.004 DBMET01477 0.142 0.004 DB00122 | DB00122 | |
| 0.251 | 0.127 | 0.474 | Sodium/bile acid cotransporter inhibitor | 0.36 0.034 DBMET03338 0.474 0.005 DBMET01477 0.258 0.12 DB00122 | DBMET01477 | |
| 0.151 | 0.029 | 0.353 | GABA C receptor antagonist | 0.147 0.031 DBMET03338 0.353 0.004 DBMET01477 0.203 0.012 DB00122 | DBMET01477 | |
| 0.123 | 0.005 | 0.163 | Nicotinic receptor alpha4 subunit antagonist | 0.081 0.013 DBMET03338 0.163 0.004 DB00122 | DB00122 | |
| 0.133 | 0.015 | 0.239 | Glutamate release inhibitor | 0.142 0.012 DBMET03338 0.239 0.004 DBMET01477 0.103 0.039 DB00122 | DBMET01477 | |
| 0.129 | 0.012 | 0.17 | Toll-Like receptor 2 agonist | 0.17 0.009 DBMET03338 0.166 0.01 DBMET01477 0.069 0.018 DB00122 | DBMET03338 | |
| 0.139 | 0.024 | 0.321 | Electrolyte absorption antagonist | 0.159 0.016 DBMET03338 0.321 0.004 DBMET01477 0.119 0.037 DB00122 | DBMET01477 | |
| 0.174 | 0.06 | 0.429 | Catenin beta inhibitor | 0.229 0.017 DBMET03338 0.429 0.004 DBMET01477 | DBMET01477 | |
| 0.165 | 0.052 | 0.232 | Hemostatic | 0.187 0.038 DBMET03338 0.232 0.024 DBMET01477 0.163 0.054 DB00122 | DBMET01477 | |
| 0.193 | 0.082 | 0.21 | Amyloid beta aggregation inhibitor | 0.178 0.09 DBMET03338 0.21 0.073 DB00122 | DB00122 | |
| 0.166 | 0.057 | 0.193 | Thiol protease inhibitor | 0.164 0.058 DBMET03338 0.193 0.042 DBMET01477 0.189 0.044 DB00122 | DBMET01477 | |
| 0.148 | 0.039 | 0.603 | Ferrochelatase inhibitor | 0.24 0.015 DBMET03338 0.603 0.002 DBMET01477 0.224 0.017 DB00122 | DBMET01477 | |
| 0.124 | 0.016 | 0.131 | Neuronal nicotinic receptor antagonist | 0.09 0.029 DBMET03338 0.131 0.015 DB00122 | DB00122 | |
| 0.111 | 0.005 | 0.111 | Nitric oxide donor | 0.105 0.007 DBMET03338 0.092 0.013 DBMET01477 0.073 0.029 DB00122 | ||
| 0.119 | 0.014 | 0.182 | Antimetabolite | 0.182 0.01 DBMET03338 0.141 0.012 DBMET01477 0.09 0.018 DB00122 | DBMET03338 | |
| 0.142 | 0.039 | 0.298 | Expectorant | 0.202 0.02 DBMET03338 0.298 0.009 DBMET01477 0.133 0.043 DB00122 | DBMET01477 | |
| 0.137 | 0.034 | 0.278 | Carbonic anhydrase III inhibitor | 0.161 0.025 DBMET03338 0.278 0.007 DBMET01477 0.138 0.034 DB00122 | DBMET01477 | |
| 0.106 | 0.004 | 0.16 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.16 0.003 DBMET03338 0.075 0.005 DBMET01477 0.076 0.005 DB00122 | DBMET03338 | |
| 0.131 | 0.032 | 0.28 | GABA C receptor rho-1 antagonist | 0.126 0.035 DBMET03338 0.28 0.004 DBMET01477 0.17 0.014 DB00122 | DBMET01477 | |
| 0.169 | 0.072 | 0.221 | ATPase inhibitor | 0.152 0.098 DBMET03338 0.221 0.023 DBMET01477 0.203 0.035 DB00122 | DBMET01477 | |
| 0.186 | 0.091 | 0.294 | Neurotrophic factor enhancer | 0.176 0.103 DBMET03338 0.294 0.02 DBMET01477 0.187 0.09 DB00122 | DBMET01477 | |
| 0.12 | 0.025 | 0.19 | Ornithine decarboxylase inhibitor | 0.138 0.015 DBMET03338 0.19 0.005 DBMET01477 0.092 0.054 DB00122 | DBMET01477 | |
| 0.117 | 0.022 | 0.734 | Glutamate decarboxylase inhibitor | 0.185 0.008 DBMET03338 0.734 0.002 DBMET01477 0.14 0.015 DB00122 | DBMET01477 | |
| 0.126 | 0.032 | 0.126 | Calcium antagonist | 0.107 0.043 DBMET01477 0.107 0.043 DB00122 | ||
| 0.109 | 0.016 | 0.246 | Glycine receptor agonist | 0.138 0.009 DBMET03338 0.246 0.003 DBMET01477 0.12 0.013 DB00122 | DBMET01477 | |
| 0.121 | 0.029 | 0.126 | Histamine N-methyltransferase inhibitor | 0.093 0.053 DBMET03338 0.122 0.028 DBMET01477 0.126 0.026 DB00122 | DB00122 | |
| 0.159 | 0.067 | 0.336 | Interferon gamma antagonist | 0.184 0.048 DBMET03338 0.336 0.015 DBMET01477 0.141 0.09 DB00122 | DBMET01477 | |
| 0.193 | 0.102 | 0.276 | Nitric-oxide synthase stimulant | 0.168 0.159 DBMET03338 0.276 0.019 DBMET01477 0.238 0.042 DB00122 | DBMET01477 | |
| 0.125 | 0.035 | 0.265 | Prolactin inhibitor | 0.139 0.027 DBMET03338 0.265 0.004 DBMET01477 0.136 0.028 DB00122 | DBMET01477 | |
| 0.101 | 0.012 | 0.106 | Acetylcholine M1 receptor agonist | 0.106 0.012 DB00122 | DB00122 | |
| 0.128 | 0.04 | 0.134 | Bronchodilator | 0.118 0.046 DBMET03338 0.134 0.038 DB00122 | DB00122 | |
| 0.093 | 0.005 | 0.093 | Acetylcholine M4 receptor agonist | 0.034 0.018 DBMET03338 0.074 0.007 DB00122 | ||
| 0.114 | 0.026 | 0.156 | Bile acid receptor antagonist | 0.13 0.013 DBMET03338 0.156 0.007 DBMET01477 0.114 0.025 DB00122 | DBMET01477 | |
| 0.242 | 0.155 | 0.509 | Immunosuppressant | 0.327 0.099 DBMET03338 0.509 0.031 DBMET01477 0.211 0.186 DB00122 | DBMET01477 | |
| 0.103 | 0.017 | 0.136 | Acetylcholine M3 receptor antagonist | 0.072 0.03 DBMET03338 0.136 0.012 DB00122 | DB00122 | |
| 0.135 | 0.049 | 0.198 | DNA intercalator | 0.093 0.082 DBMET03338 0.198 0.026 DB00122 | DB00122 | |
| 0.096 | 0.011 | 0.105 | Exportin-1 inhibitor | 0.07 0.042 DBMET03338 0.105 0.007 DBMET01477 0.075 0.034 DB00122 | DBMET01477 | |
| 0.113 | 0.031 | 0.796 | Porphobilinogen synthase inhibitor | 0.211 0.011 DBMET03338 0.796 0.002 DBMET01477 0.149 0.021 DB00122 | DBMET01477 | |
| 0.088 | 0.007 | 0.256 | Glucose-6-phosphate isomerase inhibitor | 0.119 0.004 DBMET03338 0.256 0.001 DBMET01477 0.103 0.005 DB00122 | DBMET01477 | |
| 0.114 | 0.032 | 0.355 | NADH dehydrogenase inhibitor | 0.126 0.025 DBMET03338 0.355 0.005 DBMET01477 0.204 0.01 DB00122 | DBMET01477 | |
| 0.099 | 0.018 | 0.131 | Acetylcholine M5 receptor antagonist | 0.063 0.038 DBMET03338 0.131 0.01 DB00122 | DB00122 | |
| 0.104 | 0.023 | 0.22 | Sphingosine 1-phosphate receptor 4 agonist | 0.144 0.01 DBMET03338 0.22 0.004 DBMET01477 0.13 0.013 DB00122 | DBMET01477 | |
| 0.102 | 0.023 | 0.102 | Calcium channel L-type blocker | 0.074 0.046 DBMET03338 0.089 0.031 DB00122 | ||
| 0.085 | 0.007 | 0.111 | Retinoid X receptor agonist | 0.111 0.004 DBMET03338 0.11 0.004 DBMET01477 0.08 0.008 DB00122 | DBMET03338 | |
| 0.105 | 0.027 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 DBMET03338 0.119 0.017 DBMET01477 0.104 0.028 DB00122 | DBMET01477 | |
| 0.092 | 0.014 | 0.104 | Nicotinic receptor alpha7 subunit antagonist | 0.062 0.027 DBMET03338 0.104 0.012 DB00122 | DB00122 | |
| 0.111 | 0.033 | 0.229 | Carbonic anhydrase VI inhibitor | 0.124 0.028 DBMET03338 0.229 0.01 DBMET01477 0.117 0.031 DB00122 | DBMET01477 | |
| 0.113 | 0.036 | 0.215 | Thioredoxin inhibitor | 0.111 0.037 DBMET03338 0.215 0.007 DBMET01477 | DBMET01477 | |
| 0.082 | 0.005 | 0.115 | GABA uptake inhibitor | 0.097 0.004 DBMET03338 0.115 0.003 DBMET01477 0.057 0.011 DB00122 | DBMET01477 | |
| 0.08 | 0.005 | 0.123 | Membrane dipeptidase inhibitor | 0.107 0.003 DBMET03338 0.123 0.003 DBMET01477 0.094 0.004 DB00122 | DBMET01477 | |
| 0.082 | 0.008 | 0.111 | Nicotinic receptor beta4 subunit antagonist | 0.068 0.01 DBMET03338 0.111 0.005 DB00122 | DB00122 | |
| 0.085 | 0.012 | 0.698 | Aconitate hydratase inhibitor | 0.144 0.004 DBMET03338 0.698 0.001 DBMET01477 0.086 0.012 DB00122 | DBMET01477 | |
| 0.084 | 0.011 | 0.096 | Epithelial sodium channel blocker | 0.068 0.019 DBMET03338 0.064 0.023 DBMET01477 0.096 0.008 DB00122 | DB00122 | |
| 0.098 | 0.028 | 0.109 | Lipase inhibitor | 0.075 0.048 DBMET03338 0.109 0.023 DB00122 | DB00122 | |
| 0.116 | 0.047 | 0.183 | Toll-Like receptor 4 antagonist | 0.126 0.038 DBMET03338 0.183 0.009 DBMET01477 | DBMET01477 | |
| 0.104 | 0.036 | 0.202 | Carbonic anhydrase XIII inhibitor | 0.108 0.034 DBMET03338 0.202 0.014 DBMET01477 0.095 0.04 DB00122 | DBMET01477 | |
| 0.091 | 0.024 | 0.271 | GABA B receptor agonist | 0.12 0.008 DBMET03338 0.271 0.003 DBMET01477 0.095 0.02 DB00122 | DBMET01477 | |
| 0.076 | 0.011 | 0.129 | Lysophosphatidic acid 3 receptor antagonist | 0.087 0.007 DBMET03338 0.129 0.003 DBMET01477 0.05 0.036 DB00122 | DBMET01477 | |
| 0.084 | 0.021 | 0.115 | Interferon inducer | 0.082 0.022 DBMET03338 0.115 0.008 DBMET01477 0.089 0.017 DB00122 | DBMET01477 | |
| 0.115 | 0.052 | 0.181 | Mediator release inhibitor | 0.133 0.037 DBMET03338 0.181 0.018 DBMET01477 | DBMET01477 | |
| 0.139 | 0.076 | 0.224 | Lipid peroxidase inhibitor | 0.163 0.06 DBMET03338 0.224 0.033 DBMET01477 0.117 0.097 DB00122 | DBMET01477 | |
| 0.112 | 0.049 | 0.331 | UDP-glucose 4-epimerase inhibitor | 0.105 0.055 DBMET03338 0.331 0.009 DBMET01477 0.243 0.014 DB00122 | DBMET01477 | |
| 0.079 | 0.018 | 0.107 | Glycine transporter 2 inhibitor | 0.106 0.012 DBMET03338 0.107 0.012 DBMET01477 0.064 0.023 DB00122 | DBMET01477 | |
| 0.183 | 0.123 | 0.312 | Peptidyltransferase inhibitor | 0.229 0.067 DBMET03338 0.31 0.021 DBMET01477 0.312 0.021 DB00122 | DB00122 | |
| 0.099 | 0.04 | 0.172 | Transcription factor NF kappa B stimulant | 0.114 0.028 DBMET03338 0.172 0.012 DBMET01477 | DBMET01477 | |
| 0.133 | 0.074 | 0.399 | Bone formation stimulant | 0.19 0.038 DBMET03338 0.399 0.01 DBMET01477 0.131 0.075 DB00122 | DBMET01477 | |
| 0.082 | 0.023 | 0.862 | Alcohol oxidase inhibitor | 0.122 0.014 DBMET03338 0.862 0.002 DBMET01477 0.461 0.004 DB00122 | DBMET01477 | |
| 0.092 | 0.034 | 0.407 | GABA aminotransferase inhibitor | 0.126 0.014 DBMET03338 0.407 0.003 DBMET01477 0.089 0.036 DB00122 | DBMET01477 | |
| 0.097 | 0.04 | 0.184 | Glutathione S-transferase inhibitor | 0.114 0.026 DBMET03338 0.184 0.007 DBMET01477 0.094 0.043 DB00122 | DBMET01477 | |
| 0.08 | 0.024 | 0.344 | Glutamate (mGluR6) antagonist | 0.101 0.01 DBMET03338 0.344 0.002 DBMET01477 0.081 0.023 DB00122 | DBMET01477 | |
| 0.065 | 0.01 | 0.086 | Geranyltranstransferase inhibitor | 0.067 0.009 DBMET03338 0.078 0.005 DBMET01477 0.086 0.004 DB00122 | DB00122 | |
| 0.081 | 0.026 | 0.095 | Protease 3C (Human rhinovirus) inhibitor | 0.063 0.046 DBMET03338 0.095 0.018 DBMET01477 | DBMET01477 | |
| 0.059 | 0.005 | 0.059 | Urotensin II agonist | 0.055 0.005 DBMET03338 0.037 0.01 DBMET01477 0.057 0.005 DB00122 | ||
| 0.089 | 0.035 | 0.252 | Aminopeptidase I inhibitor | 0.121 0.019 DBMET03338 0.252 0.004 DBMET01477 0.153 0.012 DB00122 | DBMET01477 | |
| 0.07 | 0.017 | 0.126 | Alpha-mannosidase inhibitor | 0.079 0.012 DBMET03338 0.126 0.004 DBMET01477 0.101 0.006 DB00122 | DBMET01477 | |
| 0.067 | 0.014 | 0.079 | Adenylate cyclase 1 inhibitor | 0.043 0.037 DBMET03338 0.079 0.008 DBMET01477 0.071 0.011 DB00122 | DBMET01477 | |
| 0.119 | 0.066 | 0.295 | Cholesterol synthesis inhibitor | 0.155 0.042 DBMET03338 0.295 0.012 DBMET01477 0.125 0.061 DB00122 | DBMET01477 | |
| 0.108 | 0.056 | 0.148 | Gastric antisecretory | 0.107 0.057 DBMET03338 0.148 0.027 DBMET01477 | DBMET01477 | |
| 0.116 | 0.065 | 0.197 | Microtubule formation inhibitor | 0.109 0.075 DBMET03338 0.197 0.02 DBMET01477 0.109 0.075 DB00122 | DBMET01477 | |
| 0.096 | 0.046 | 0.141 | Bromodomain-containing protein 2 inhibitor | 0.141 0.012 DB00122 | DB00122 | |
| 0.071 | 0.021 | 0.115 | Peroxisome proliferator-activated receptor alpha agonist | 0.115 0.01 DBMET03338 0.113 0.01 DBMET01477 0.045 0.036 DB00122 | DBMET03338 | |
| 0.185 | 0.135 | 0.539 | Superoxide dismutase inhibitor | 0.192 0.127 DBMET03338 0.539 0.01 DBMET01477 0.297 0.051 DB00122 | DBMET01477 | |
| 0.102 | 0.052 | 0.507 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.15 0.026 DBMET03338 0.507 0.002 DBMET01477 0.138 0.031 DB00122 | DBMET01477 | |
| 0.104 | 0.055 | 0.301 | Creatine kinase inhibitor | 0.116 0.044 DBMET03338 0.301 0.004 DBMET01477 0.243 0.006 DB00122 | DBMET01477 | |
| 0.089 | 0.042 | 0.089 | Thioredoxin reductase inhibitor | 0.087 0.045 DBMET03338 0.085 0.049 DBMET01477 | ||
| 0.062 | 0.016 | 0.062 | Cholesterol esterase inhibitor | 0.043 0.042 DBMET03338 0.047 0.034 DBMET01477 0.054 0.023 DB00122 | ||
| 0.14 | 0.095 | 0.574 | Growth hormone agonist | 0.268 0.039 DBMET03338 0.574 0.004 DBMET01477 | DBMET01477 | |
| 0.092 | 0.048 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.149 0.005 DBMET01477 0.096 0.041 DB00122 | DBMET01477 | |
| 0.047 | 0.004 | 0.068 | Lysophosphatidic acid receptor 1 agonist | 0.05 0.004 DBMET03338 0.068 0.003 DBMET01477 0.036 0.007 DB00122 | DBMET01477 | |
| 0.06 | 0.017 | 0.154 | Mannosidase inhibitor | 0.075 0.01 DBMET03338 0.154 0.004 DBMET01477 0.088 0.007 DB00122 | DBMET01477 | |
| 0.081 | 0.039 | 0.132 | Vanilloid 4 agonist | 0.079 0.043 DBMET03338 0.132 0.004 DBMET01477 0.087 0.03 DB00122 | DBMET01477 | |
| 0.07 | 0.028 | 0.141 | Carbonic anhydrase VB inhibitor | 0.065 0.031 DBMET03338 0.141 0.01 DBMET01477 0.082 0.021 DB00122 | DBMET01477 | |
| 0.068 | 0.026 | 0.26 | Ornithine carbamoyltransferase inhibitor | 0.087 0.019 DBMET03338 0.26 0.005 DBMET01477 0.108 0.014 DB00122 | DBMET01477 | |
| 0.06 | 0.018 | 0.074 | Carnitine palmitoyltransferase 1B inhibitor | 0.07 0.011 DBMET03338 0.068 0.012 DBMET01477 0.074 0.009 DB00122 | DB00122 | |
| 0.044 | 0.003 | 0.091 | Carbonic anhydrase VIII inhibitor | 0.053 0.002 DBMET03338 0.091 0.001 DBMET01477 0.02 0.009 DB00122 | DBMET01477 | |
| 0.044 | 0.003 | 0.091 | Carbonic anhydrase X inhibitor | 0.053 0.002 DBMET03338 0.091 0.001 DBMET01477 0.02 0.009 DB00122 | DBMET01477 | |
| 0.066 | 0.025 | 0.08 | Lipocortins synthesis agonist | 0.068 0.024 DBMET03338 0.08 0.013 DBMET01477 | DBMET01477 | |
| 0.117 | 0.077 | 0.164 | DNA repair enzyme inhibitor | 0.118 0.077 DBMET03338 0.164 0.021 DBMET01477 0.11 0.096 DB00122 | DBMET01477 | |
| 0.065 | 0.025 | 0.065 | Elastase inhibitor | 0.049 0.043 DBMET03338 | ||
| 0.043 | 0.004 | 0.047 | Vanilloid 2 agonist | 0.038 0.004 DBMET03338 0.044 0.004 DBMET01477 0.047 0.003 DB00122 | DB00122 | |
| 0.132 | 0.093 | 0.311 | Diuretic | 0.176 0.056 DBMET03338 0.311 0.021 DBMET01477 | DBMET01477 | |
| 0.048 | 0.009 | 0.059 | Carnitine palmitoyltransferase inhibitor | 0.059 0.005 DBMET03338 0.05 0.008 DBMET01477 0.055 0.006 DB00122 | DBMET03338 | |
| 0.068 | 0.029 | 0.082 | Potassium channel intermediate-conductance Ca-activated blocker | 0.082 0.016 DBMET01477 | DBMET01477 | |
| 0.054 | 0.017 | 0.156 | Glutamate (mGluR4) antagonist | 0.081 0.008 DBMET03338 0.156 0.004 DBMET01477 | DBMET01477 | |
| 0.099 | 0.062 | 0.181 | Glutamate (mGluR7) agonist | 0.098 0.063 DBMET03338 0.181 0.005 DBMET01477 0.094 0.073 DB00122 | DBMET01477 | |
| 0.045 | 0.01 | 0.054 | Carnitine palmitoyltransferase 1 inhibitor | 0.054 0.006 DBMET03338 0.048 0.009 DBMET01477 0.053 0.006 DB00122 | DBMET03338 | |
| 0.043 | 0.009 | 0.069 | Carnitine palmitoyltransferase 1A inhibitor | 0.041 0.009 DBMET03338 0.069 0.005 DB00122 | DB00122 | |
| 0.048 | 0.014 | 0.64 | Fumarate hydratase inhibitor | 0.087 0.006 DBMET03338 0.64 0.001 DBMET01477 0.047 0.015 DB00122 | DBMET01477 | |
| 0.089 | 0.056 | 0.116 | Antineoplastic alkaloid | 0.092 0.053 DBMET03338 0.116 0.039 DBMET01477 0.111 0.042 DB00122 | DBMET01477 | |
| 0.085 | 0.052 | 0.085 | Histamine H1 receptor antagonist | 0.077 0.061 DBMET03338 | ||
| 0.043 | 0.011 | 0.065 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.044 0.011 DBMET03338 0.065 0.006 DBMET01477 0.051 0.009 DB00122 | DBMET01477 | |
| 0.093 | 0.062 | 0.093 | Toll-Like receptor 3 antagonist | |||
| 0.04 | 0.009 | 0.04 | Elastase 3A inhibitor | 0.03 0.022 DBMET03338 0.035 0.013 DBMET01477 | ||
| 0.04 | 0.009 | 0.04 | Elastase 3B inhibitor | 0.03 0.022 DBMET03338 0.035 0.013 DBMET01477 | ||
| 0.04 | 0.009 | 0.04 | Elastase 2B inhibitor | 0.03 0.022 DBMET03338 0.035 0.013 DBMET01477 | ||
| 0.066 | 0.035 | 0.374 | Biliverdin reductase inhibitor | 0.111 0.016 DBMET03338 0.374 0.002 DBMET01477 0.111 0.016 DB00122 | DBMET01477 | |
| 0.034 | 0.003 | 0.049 | Lysophosphatidic acid receptor 3 agonist | 0.029 0.004 DBMET03338 0.049 0.002 DBMET01477 0.021 0.005 DB00122 | DBMET01477 | |
| 0.125 | 0.095 | 0.588 | Peroxidase inhibitor | 0.149 0.078 DBMET03338 0.588 0.005 DBMET01477 0.385 0.023 DB00122 | DBMET01477 | |
| 0.04 | 0.011 | 0.046 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.013 DBMET03338 0.046 0.005 DBMET01477 | DBMET01477 | |
| 0.072 | 0.044 | 0.411 | Phenylalanine 4-hydroxylase inhibitor | 0.127 0.016 DBMET03338 0.411 0.003 DBMET01477 0.181 0.008 DB00122 | DBMET01477 | |
| 0.042 | 0.014 | 0.053 | Ceramide glucosyltransferase inhibitor | 0.044 0.011 DBMET03338 0.047 0.009 DBMET01477 0.053 0.005 DB00122 | DB00122 | |
| 0.058 | 0.031 | 0.145 | Thromboxane synthase inhibitor | 0.081 0.011 DBMET03338 0.145 0.004 DBMET01477 | DBMET01477 | |
| 0.117 | 0.09 | 0.117 | Calcium channel blocker | |||
| 0.06 | 0.034 | 0.181 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.067 0.028 DBMET03338 0.181 0.007 DBMET01477 0.137 0.009 DB00122 | DBMET01477 | |
| 0.105 | 0.081 | 0.317 | DNA polymerase I inhibitor | 0.158 0.045 DBMET03338 0.317 0.01 DBMET01477 | DBMET01477 | |
| 0.052 | 0.03 | 0.067 | Squalene epoxidase inhibitor | 0.057 0.024 DBMET01477 0.067 0.015 DB00122 | DB00122 | |
| 0.059 | 0.037 | 0.354 | Argininosuccinate synthase inhibitor | 0.103 0.018 DBMET03338 0.354 0.003 DBMET01477 0.079 0.026 DB00122 | DBMET01477 | |
| 0.158 | 0.137 | 0.21 | Antiamyloidogenic | 0.16 0.134 DBMET03338 0.21 0.093 DBMET01477 | DBMET01477 | |
| 0.066 | 0.045 | 0.076 | Beta adrenoreceptor antagonist | 0.069 0.04 DBMET03338 0.076 0.031 DBMET01477 0.064 0.049 DB00122 | DBMET01477 | |
| 0.041 | 0.021 | 0.118 | Arginase inhibitor | 0.058 0.011 DBMET03338 0.118 0.003 DBMET01477 0.056 0.012 DB00122 | DBMET01477 | |
| 0.056 | 0.037 | 0.115 | Ribonucleoside-diphosphate reductase inhibitor | 0.082 0.024 DBMET03338 0.115 0.016 DBMET01477 0.056 0.037 DB00122 | DBMET01477 | |
| 0.037 | 0.018 | 0.055 | Adenosine uptake inhibitor | 0.055 0.004 DB00122 | DB00122 | |
| 0.041 | 0.022 | 0.173 | Glutamate (mGluR8) agonist | 0.054 0.009 DBMET03338 0.173 0.001 DBMET01477 0.042 0.02 DB00122 | DBMET01477 | |
| 0.078 | 0.06 | 0.168 | Glycine receptor antagonist | 0.078 0.06 DBMET03338 0.168 0.005 DBMET01477 0.084 0.05 DB00122 | DBMET01477 | |
| 0.068 | 0.049 | 0.138 | Carbonic anhydrase VA inhibitor | 0.068 0.049 DBMET03338 0.138 0.013 DBMET01477 0.074 0.042 DB00122 | DBMET01477 | |
| 0.057 | 0.038 | 0.114 | Ribonucleotide reductase inhibitor | 0.082 0.026 DBMET03338 0.114 0.018 DBMET01477 0.057 0.038 DB00122 | DBMET01477 | |
| 0.09 | 0.072 | 0.161 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 DBMET03338 0.161 0.008 DBMET01477 0.088 0.075 DB00122 | DBMET01477 | |
| 0.079 | 0.062 | 0.175 | ErbB-3 antagonist | 0.093 0.047 DBMET03338 0.175 0.013 DBMET01477 | DBMET01477 | |
| 0.045 | 0.028 | 0.146 | Glutamate (mGluR group III) antagonist | 0.059 0.014 DBMET03338 0.146 0.004 DBMET01477 | DBMET01477 | |
| 0.048 | 0.031 | 0.049 | Microtubule stabilization | 0.046 0.033 DBMET03338 0.049 0.03 DBMET01477 | DBMET01477 | |
| 0.026 | 0.009 | 0.034 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET03338 0.034 0.004 DBMET01477 0.021 0.019 DB00122 | DBMET01477 | |
| 0.086 | 0.07 | 0.086 | Antihistaminic | |||
| 0.033 | 0.018 | 0.121 | Lysophosphatidic acid 2 receptor antagonist | 0.039 0.013 DBMET03338 0.121 0.004 DBMET01477 | DBMET01477 | |
| 0.13 | 0.114 | 0.263 | Melanin inhibitor | 0.139 0.098 DBMET03338 0.263 0.027 DBMET01477 0.148 0.085 DB00122 | DBMET01477 | |
| 0.026 | 0.011 | 0.079 | Prostaglandin F2 alpha agonist | 0.041 0.005 DBMET03338 0.079 0.002 DBMET01477 0.023 0.015 DB00122 | DBMET01477 | |
| 0.131 | 0.116 | 0.198 | Heat shock protein 70 antagonist | 0.137 0.087 DBMET03338 0.198 0.007 DBMET01477 0.143 0.066 DB00122 | DBMET01477 | |
| 0.088 | 0.075 | 0.192 | Interleukin 1 beta converting enzyme inhibitor | 0.128 0.029 DBMET03338 0.192 0.007 DBMET01477 | DBMET01477 | |
| 0.055 | 0.042 | 0.102 | Leukotriene C antagonist | 0.065 0.02 DBMET03338 0.102 0.004 DBMET01477 | DBMET01477 | |
| 0.02 | 0.007 | 0.025 | Nicotinic alpha4 receptor agonist | 0.025 0.005 DB00122 | DB00122 | |
| 0.049 | 0.038 | 0.101 | Diacylglycerol O-acyltransferase inhibitor | 0.076 0.016 DBMET03338 0.101 0.007 DBMET01477 0.052 0.034 DB00122 | DBMET01477 | |
| 0.02 | 0.009 | 0.032 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET03338 0.032 0.002 DBMET01477 0.02 0.008 DB00122 | DBMET01477 | |
| 0.046 | 0.036 | 0.046 | Benzodiazepine antagonist | |||
| 0.045 | 0.035 | 0.115 | Thymidylate synthase inhibitor | 0.065 0.014 DBMET03338 0.115 0.004 DBMET01477 0.057 0.02 DB00122 | DBMET01477 | |
| 0.029 | 0.019 | 0.05 | Estrogen-related receptor gamma antagonist | 0.028 0.02 DBMET03338 0.038 0.006 DBMET01477 0.05 0.003 DB00122 | DB00122 | |
| 0.045 | 0.036 | 0.082 | Adenosine deaminase inhibitor | 0.051 0.029 DBMET03338 0.082 0.009 DBMET01477 0.061 0.02 DB00122 | DBMET01477 | |
| 0.036 | 0.028 | 0.169 | Cholecystokinin B agonist | 0.049 0.016 DBMET03338 0.169 0.005 DBMET01477 | DBMET01477 | |
| 0.015 | 0.006 | 0.037 | Carbonic anhydrase XI inhibitor | 0.015 0.006 DBMET03338 0.037 0.002 DBMET01477 | DBMET01477 | |
| 0.059 | 0.05 | 0.116 | 5 Hydroxytryptamine 3 agonist | 0.116 0.01 DB00122 | DB00122 | |
| 0.027 | 0.019 | 0.038 | Hedgehog signaling activator | 0.038 0.005 DBMET01477 0.03 0.012 DB00122 | DBMET01477 | |
| 0.042 | 0.035 | 0.042 | Oleamide hydrolase inhibitor | 0.039 0.038 DBMET01477 | ||
| 0.045 | 0.038 | 0.092 | Carbonic anhydrase XIV inhibitor | 0.047 0.036 DBMET03338 0.092 0.013 DBMET01477 | DBMET01477 | |
| 0.019 | 0.012 | 0.024 | Estrogen-related receptor gamma agonist | 0.018 0.015 DBMET03338 0.024 0.006 DBMET01477 0.022 0.007 DB00122 | DBMET01477 | |
| 0.04 | 0.033 | 0.127 | Kainate receptor agonist | 0.046 0.02 DBMET03338 0.127 0.002 DBMET01477 0.046 0.02 DB00122 | DBMET01477 | |
| 0.05 | 0.044 | 0.113 | Leukotriene B4 antagonist | 0.068 0.021 DBMET03338 0.113 0.008 DBMET01477 | DBMET01477 | |
| 0.036 | 0.032 | 0.098 | Dihydropteroate synthase inhibitor | 0.04 0.026 DBMET03338 0.098 0.005 DBMET01477 0.041 0.025 DB00122 | DBMET01477 | |
| 0.031 | 0.027 | 0.104 | Glutamate (mGluR3) agonist | 0.039 0.01 DBMET03338 0.104 0.002 DBMET01477 0.034 0.018 DB00122 | DBMET01477 | |
| 0.059 | 0.055 | 0.149 | Carbonic anhydrase V inhibitor | 0.059 0.054 DBMET03338 0.149 0.015 DBMET01477 0.07 0.043 DB00122 | DBMET01477 | |
| 0.063 | 0.059 | 0.372 | Histidine decarboxylase inhibitor | 0.081 0.042 DBMET03338 0.372 0.004 DBMET01477 0.081 0.042 DB00122 | DBMET01477 | |
| 0.074 | 0.071 | 0.074 | Histamine antagonist | |||
| 0.018 | 0.015 | 0.026 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET03338 0.026 0.004 DBMET01477 0.024 0.006 DB00122 | DBMET01477 | |
| 0.053 | 0.05 | 0.152 | Carbonic anhydrase stimulant | 0.067 0.034 DBMET03338 0.152 0.011 DBMET01477 | DBMET01477 | |
| 0.015 | 0.012 | 0.061 | Thromboxane A2 agonist | 0.022 0.005 DBMET03338 0.061 0.002 DBMET01477 | DBMET01477 | |
| 0.02 | 0.017 | 0.051 | Lysophosphatidic acid 1 receptor antagonist | 0.028 0.008 DBMET03338 0.051 0.004 DBMET01477 | DBMET01477 | |
| 0.026 | 0.024 | 0.026 | Glucosylceramidase stimulant | 0.026 0.024 DBMET01477 | ||
| 0.014 | 0.012 | 0.189 | Prostacyclin agonist | 0.033 0.005 DBMET03338 0.189 0.002 DBMET01477 | DBMET01477 | |
| 0.04 | 0.038 | 0.132 | AICAR transformylase inhibitor | 0.055 0.018 DBMET03338 0.132 0.003 DBMET01477 | DBMET01477 | |
| 0.024 | 0.022 | 0.143 | Lysine carboxypeptidase inhibitor | 0.037 0.011 DBMET03338 0.143 0.003 DBMET01477 0.032 0.014 DB00122 | DBMET01477 | |
| 0.027 | 0.025 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DB00122 | DB00122 | |
| 0.053 | 0.052 | 0.099 | Pregnane X receptor antagonist | 0.053 0.051 DBMET03338 0.099 0.004 DBMET01477 0.056 0.04 DB00122 | DBMET01477 | |
| 0.108 | 0.107 | 0.115 | Toll-Like receptor antagonist | 0.115 0.092 DBMET01477 | DBMET01477 | |
| 0.045 | 0.045 | 0.056 | Cytokine production stimulant | 0.056 0.018 DBMET01477 0.048 0.033 DB00122 | DBMET01477 | |
| 0.01 | 0.01 | 0.014 | Immunosuppressant Cyclosporine-like | 0.014 0.005 DB00122 | DB00122 | |
| 0.014 | 0.015 | 0.02 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET01477 0.014 0.013 DB00122 | DBMET01477 | |
| 0.03 | 0.031 | 0.087 | Phosphoglycerate kinase inhibitor | 0.038 0.021 DBMET03338 0.087 0.008 DBMET01477 0.061 0.011 DB00122 | DBMET01477 | |
| 0.089 | 0.091 | 0.344 | Cystathionine beta-synthase inhibitor | 0.107 0.07 DBMET03338 0.344 0.007 DBMET01477 0.13 0.051 DB00122 | DBMET01477 | |
| 0.024 | 0.027 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET01477 | DBMET01477 | |
| 0.097 | 0.1 | 0.349 | Amylase inhibitor | 0.153 0.062 DBMET03338 0.349 0.013 DBMET01477 0.128 0.076 DB00122 | DBMET01477 | |
| 0.044 | 0.047 | 0.068 | Dopamine beta hydroxylase inhibitor | 0.068 0.009 DBMET01477 0.045 0.044 DB00122 | DBMET01477 | |
| 0.046 | 0.05 | 0.057 | Autotaxin inhibitor | 0.048 0.044 DBMET03338 0.057 0.031 DBMET01477 | DBMET01477 | |
| 0.036 | 0.04 | 0.076 | Leukotriene C4 antagonist | 0.043 0.019 DBMET03338 0.076 0.004 DBMET01477 | DBMET01477 | |
| 0.038 | 0.043 | 0.073 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.037 DBMET03338 0.073 0.01 DBMET01477 | DBMET01477 | |
| 0.027 | 0.031 | 0.068 | Calcitonin receptor agonist | 0.033 0.024 DBMET03338 0.068 0.013 DBMET01477 | DBMET01477 | |
| 0.014 | 0.019 | 0.025 | Vitamin D receptor agonist | 0.017 0.011 DBMET03338 0.025 0.004 DBMET01477 0.016 0.014 DB00122 | DBMET01477 | |
| 0.062 | 0.067 | 0.095 | Epoxide hydrolase inhibitor | 0.095 0.029 DBMET01477 | DBMET01477 | |
| 0.022 | 0.028 | 0.044 | Calcium-sensing receptor agonist | 0.026 0.019 DBMET03338 0.044 0.006 DBMET01477 0.031 0.012 DB00122 | DBMET01477 | |
| 0.008 | 0.014 | 0.011 | Calcineurin inhibitor | 0.011 0.008 DBMET01477 | DBMET01477 | |
| 0.022 | 0.028 | 0.047 | Bradykinin B2 receptor antagonist | 0.047 0.009 DB00122 | DB00122 | |
| 0.042 | 0.048 | 0.059 | Beta 2 adrenoreceptor antagonist | 0.047 0.041 DBMET03338 0.059 0.025 DBMET01477 | DBMET01477 | |
| 0.091 | 0.097 | 0.238 | DOPA decarboxylase inhibitor | 0.1 0.076 DBMET03338 0.238 0.004 DBMET01477 0.124 0.041 DB00122 | DBMET01477 | |
| 0.01 | 0.017 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET01477 0.013 0.009 DB00122 | DBMET01477 | |
| 0.06 | 0.067 | 0.076 | Amidase inhibitor | 0.076 0.042 DBMET01477 | DBMET01477 | |
| 0.018 | 0.025 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.018 DBMET01477 | DBMET01477 | |
| 0.022 | 0.029 | 0.062 | Thyroid hormone agonist | 0.032 0.011 DBMET03338 0.062 0.004 DBMET01477 | DBMET01477 | |
| 0.012 | 0.02 | 0.043 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET03338 0.043 0.004 DBMET01477 0.018 0.011 DB00122 | DBMET01477 | |
| 0.037 | 0.044 | 0.106 | Sphingosine 1-phosphate receptor agonist | 0.059 0.017 DBMET03338 0.106 0.005 DBMET01477 0.05 0.024 DB00122 | DBMET01477 | |
| 0.062 | 0.07 | 0.08 | Topoisomerase II alpha inhibitor | 0.08 0.053 DB00122 | DB00122 | |
| 0.057 | 0.065 | 0.067 | Beta 2 adrenoreceptor agonist | 0.065 0.033 DBMET01477 0.067 0.027 DB00122 | DB00122 | |
| 0.009 | 0.017 | 0.031 | Calcium-dependent phospholipase A2 inhibitor | 0.031 0.004 DBMET01477 | DBMET01477 | |
| 0.085 | 0.094 | 0.152 | Carbonic anhydrase XV inhibitor | 0.152 0.03 DBMET01477 0.152 0.03 DB00122 | DB00122 | |
| 0.062 | 0.073 | 0.091 | CYP2A6 inhibitor | 0.091 0.04 DBMET01477 | DBMET01477 | |
| 0.126 | 0.137 | 0.39 | Platelet adhesion inhibitor | 0.198 0.072 DBMET03338 0.39 0.013 DBMET01477 | DBMET01477 | |
| 0.037 | 0.048 | 0.127 | Thromboxane A2 antagonist | 0.073 0.019 DBMET03338 0.127 0.005 DBMET01477 | DBMET01477 | |
| 0.024 | 0.035 | 0.042 | Purinergic P2Y15 antagonist | 0.042 0.006 DBMET01477 0.033 0.013 DB00122 | DBMET01477 | |
| 0.021 | 0.033 | 0.043 | Integrin alpha2beta1 antagonist | 0.043 0.005 DBMET01477 | DBMET01477 | |
| 0.041 | 0.053 | 0.075 | Bombesin 2 receptor antagonist | 0.075 0.018 DBMET01477 0.045 0.042 DB00122 | DBMET01477 | |
| 0.008 | 0.019 | 0.135 | Glutamate (mGluR6) agonist | 0.012 0.009 DBMET03338 0.135 0.001 DBMET01477 | DBMET01477 | |
| 0.032 | 0.044 | 0.06 | Oxytocin agonist | 0.06 0.017 DBMET01477 0.043 0.029 DB00122 | DBMET01477 | |
| 0.017 | 0.029 | 0.049 | Retinoid X beta receptor antagonist | 0.021 0.014 DBMET03338 0.049 0.003 DBMET01477 | DBMET01477 | |
| 0.033 | 0.046 | 0.088 | Sphingosine 1-phosphate receptor 1 agonist | 0.051 0.019 DBMET03338 0.088 0.005 DBMET01477 0.052 0.018 DB00122 | DBMET01477 | |
| 0.006 | 0.02 | 0.061 | Thromboxane agonist | 0.011 0.008 DBMET03338 0.061 0.002 DBMET01477 | DBMET01477 | |
| 0.052 | 0.066 | 0.352 | Peroxisome proliferator-activated receptor gamma agonist | 0.118 0.021 DBMET03338 0.352 0.004 DBMET01477 | DBMET01477 | |
| 0.03 | 0.043 | 0.048 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.048 0.013 DB00122 | DB00122 | |
| 0.03 | 0.044 | 0.076 | Integrin alpha2 antagonist | 0.04 0.02 DBMET03338 0.076 0.005 DBMET01477 | DBMET01477 | |
| 0.027 | 0.041 | 0.051 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET03338 0.051 0.006 DBMET01477 | DBMET01477 | |
| 0.043 | 0.057 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.067 0.029 DBMET01477 | DBMET01477 | |
| 0.013 | 0.027 | 0.029 | Telomerase stimulant | 0.029 0.003 DBMET01477 0.016 0.013 DB00122 | DBMET01477 | |
| 0.04 | 0.054 | 0.141 | Thromboxane antagonist | 0.077 0.022 DBMET03338 0.141 0.005 DBMET01477 | DBMET01477 | |
| 0.053 | 0.067 | 0.236 | Caspase 9 inhibitor | 0.087 0.019 DBMET03338 0.236 0.004 DBMET01477 | DBMET01477 | |
| 0.016 | 0.03 | 0.06 | Prostaglandin H2 antagonist | 0.032 0.011 DBMET03338 0.06 0.003 DBMET01477 | DBMET01477 | |
| 0.058 | 0.073 | 0.204 | Cathepsin G inhibitor | 0.072 0.051 DBMET03338 0.204 0.016 DBMET01477 | DBMET01477 | |
| 0.013 | 0.029 | 0.082 | Prostaglandin EP2 agonist | 0.031 0.012 DBMET03338 0.082 0.004 DBMET01477 | DBMET01477 | |
| 0.015 | 0.03 | 0.021 | Corticosteroid-like | 0.021 0.015 DBMET01477 | DBMET01477 | |
| 0.051 | 0.066 | 0.298 | Prostaglandin F2 alpha antagonist | 0.094 0.014 DBMET03338 0.298 0.003 DBMET01477 | DBMET01477 | |
| 0.009 | 0.026 | 0.022 | Integrin alphaVbeta6 antagonist | 0.013 0.011 DBMET03338 0.022 0.005 DBMET01477 | DBMET01477 | |
| 0.019 | 0.036 | 0.135 | Glutamate (mGluR1) agonist | 0.023 0.021 DBMET03338 0.135 0.003 DBMET01477 | DBMET01477 | |
| 0.091 | 0.108 | 0.215 | Caspase 3 inhibitor | 0.127 0.05 DBMET03338 0.215 0.008 DBMET01477 | DBMET01477 | |
| 0.05 | 0.068 | 0.281 | NMDA receptor agonist | 0.082 0.028 DBMET03338 0.281 0.003 DBMET01477 0.084 0.026 DB00122 | DBMET01477 | |
| 0.064 | 0.082 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 DBMET01477 | DBMET01477 | |
| 0.036 | 0.054 | 0.068 | Dihydrofolate reductase inhibitor | 0.068 0.007 DBMET01477 | DBMET01477 | |
| 0.003 | 0.022 | 0.007 | DNA polymerase III subunit alpha inhibitor | 0.007 0.004 DBMET01477 | DBMET01477 | |
| 0.076 | 0.095 | 0.099 | Topoisomerase I inhibitor | 0.096 0.073 DBMET01477 0.099 0.071 DB00122 | DB00122 | |
| 0.109 | 0.128 | 0.208 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.097 DBMET03338 0.208 0.006 DBMET01477 0.145 0.047 DB00122 | DBMET01477 | |
| 0.034 | 0.055 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.08 0.004 DBMET01477 0.052 0.013 DB00122 | DBMET01477 | |
| 0.027 | 0.048 | 0.243 | Glutamate (mGluR3) antagonist | 0.037 0.024 DBMET03338 0.243 0.003 DBMET01477 | DBMET01477 | |
| 0.015 | 0.035 | 0.179 | Glutamate (mGluR1a) agonist | 0.179 0.002 DBMET01477 | DBMET01477 | |
| 0.029 | 0.05 | 0.04 | Glutamate (mGluR1a) antagonist | 0.04 0.03 DBMET01477 0.036 0.035 DB00122 | DBMET01477 | |
| 0.009 | 0.032 | 0.045 | Aminopeptidase A inhibitor | 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.004 | 0.027 | 0.045 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.045 0.002 DBMET01477 | DBMET01477 | |
| 0.014 | 0.037 | 0.034 | Caspase 8 inhibitor | 0.019 0.015 DBMET03338 0.034 0.004 DBMET01477 | DBMET01477 | |
| 0.039 | 0.062 | 0.065 | Prolyl endopeptidase inhibitor | 0.065 0.019 DBMET01477 | DBMET01477 | |
| 0.034 | 0.057 | 0.119 | GABA B receptor antagonist | 0.039 0.038 DBMET03338 0.119 0.004 DBMET01477 | DBMET01477 | |
| 0.02 | 0.044 | 0.147 | Prostaglandin agonist | 0.034 0.018 DBMET03338 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.162 | 0.187 | 0.292 | Lipoxygenase inhibitor | 0.191 0.15 DBMET03338 0.292 0.075 DBMET01477 | DBMET01477 | |
| 0.048 | 0.073 | 0.149 | Leukotriene antagonist | 0.074 0.037 DBMET03338 0.149 0.01 DBMET01477 | DBMET01477 | |
| 0.027 | 0.052 | 0.071 | Carbonic anhydrase IV inhibitor | 0.071 0.014 DBMET01477 | DBMET01477 | |
| 0.055 | 0.081 | 0.128 | Glutamate (mGluR7) antagonist | 0.128 0.004 DBMET01477 0.067 0.048 DB00122 | DBMET01477 | |
| 0.013 | 0.039 | 0.021 | CXC chemokine 5 receptor antagonist | 0.021 0.007 DBMET01477 | DBMET01477 | |
| 0.025 | 0.052 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.022 DBMET01477 0.031 0.029 DB00122 | DBMET01477 | |
| 0.016 | 0.042 | 0.076 | Squalene synthetase inhibitor | 0.076 0.009 DBMET01477 | DBMET01477 | |
| 0.031 | 0.057 | 0.045 | Histamine H2 receptor agonist | 0.045 0.027 DBMET01477 | DBMET01477 | |
| 0.015 | 0.042 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 DBMET01477 0.021 0.014 DB00122 | DBMET01477 | |
| 0.028 | 0.055 | 0.084 | Dopamine D5 agonist | 0.084 0.005 DBMET01477 0.04 0.027 DB00122 | DBMET01477 | |
| 0.006 | 0.033 | 0.397 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.016 0.009 DBMET03338 0.397 0.002 DBMET01477 | DBMET01477 | |
| 0.067 | 0.095 | 0.106 | MAP kinase kinase 7 inhibitor | 0.101 0.012 DBMET01477 0.106 0.009 DB00122 | DB00122 | |
| 0.029 | 0.058 | 0.074 | Guanylate cyclase inhibitor | 0.074 0.004 DBMET01477 0.058 0.013 DB00122 | DBMET01477 | |
| 0.019 | 0.048 | 0.056 | Peptide deformylase inhibitor | 0.056 0.008 DBMET01477 | DBMET01477 | |
| 0.031 | 0.06 | 0.056 | Neurotensin receptor antagonist | 0.056 0.025 DBMET01477 | DBMET01477 | |
| 0.004 | 0.034 | 0.018 | Thyroid hormone beta agonist | 0.018 0.004 DBMET01477 | DBMET01477 | |
| 0.06 | 0.09 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.095 0.017 DBMET01477 0.078 0.041 DB00122 | DBMET01477 | |
| 0.029 | 0.06 | 0.041 | Neurokinin 2 agonist | 0.041 0.029 DBMET01477 | DBMET01477 | |
| 0.019 | 0.049 | 0.268 | Leukotriene A4 hydrolase inhibitor | 0.055 0.018 DBMET03338 0.268 0.004 DBMET01477 | DBMET01477 | |
| 0.004 | 0.035 | 0.015 | Carboxypeptidase B2 inhibitor | 0.015 0.005 DBMET01477 | DBMET01477 | |
| 0.17 | 0.202 | 0.373 | Transcription factor NF kappa B inhibitor | 0.373 0.07 DBMET01477 | DBMET01477 | |
| 0.023 | 0.056 | 0.075 | HMG CoA reductase inhibitor | 0.038 0.017 DBMET03338 0.075 0.004 DBMET01477 | DBMET01477 | |
| 0.021 | 0.054 | 0.128 | Retinoid X alpha receptor agonist | 0.033 0.027 DBMET03338 0.128 0.004 DBMET01477 | DBMET01477 | |
| 0.015 | 0.049 | 0.031 | Retinoic acid receptor agonist | 0.031 0.009 DBMET01477 | DBMET01477 | |
| 0.018 | 0.052 | 0.113 | Prostaglandin D2 agonist | 0.04 0.012 DBMET03338 0.113 0.003 DBMET01477 | DBMET01477 | |
| 0.027 | 0.062 | 0.072 | Retinoid X receptor antagonist | 0.035 0.032 DBMET03338 0.072 0.004 DBMET01477 | DBMET01477 | |
| 0.16 | 0.195 | 0.249 | 12-Lipoxygenase inhibitor | 0.249 0.11 DBMET01477 | DBMET01477 | |
| 0.163 | 0.198 | 0.25 | Neuropeptide Y2 antagonist | 0.25 0.057 DBMET01477 | DBMET01477 | |
| 0.029 | 0.064 | 0.065 | Leukocyte elastase inhibitor | 0.065 0.016 DBMET01477 | DBMET01477 | |
| 0.005 | 0.04 | 0.118 | Prostaglandin EP4 agonist | 0.118 0.003 DBMET01477 | DBMET01477 | |
| 0.183 | 0.22 | 0.548 | Interleukin 2 agonist | 0.322 0.059 DBMET03338 0.548 0.005 DBMET01477 0.208 0.176 DB00122 | DBMET01477 | |
| 0.01 | 0.048 | 0.102 | Prostaglandin E2 agonist | 0.021 0.02 DBMET03338 0.102 0.004 DBMET01477 | DBMET01477 | |
| 0.024 | 0.062 | 0.06 | Retinoid X alpha receptor antagonist | 0.06 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.049 | 0.172 | Purinergic P2Y12 antagonist | 0.021 0.017 DBMET03338 0.172 0.004 DBMET01477 | DBMET01477 | |
| 0.041 | 0.079 | 0.077 | Glucosylceramidase inhibitor | 0.065 0.026 DBMET01477 0.077 0.017 DB00122 | DB00122 | |
| 0.02 | 0.058 | 0.051 | Epoxide hydrolase 1 inhibitor | 0.051 0.005 DBMET01477 | DBMET01477 | |
| 0.069 | 0.109 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.039 DBMET01477 | DBMET01477 | |
| 0.024 | 0.065 | 0.108 | Purinergic P2Y antagonist | 0.04 0.037 DBMET03338 0.108 0.008 DBMET01477 | DBMET01477 | |
| 0.146 | 0.186 | 0.225 | Calpain inhibitor | 0.225 0.09 DBMET01477 | DBMET01477 | |
| 0.032 | 0.073 | 0.049 | CC chemokine 4 receptor antagonist | 0.049 0.028 DBMET01477 | DBMET01477 | |
| 0.048 | 0.089 | 0.104 | Elastase 1 inhibitor | 0.104 0.018 DBMET01477 | DBMET01477 | |
| 0.013 | 0.054 | 0.071 | Uridine phosphorylase inhibitor | 0.071 0.004 DBMET01477 0.044 0.01 DB00122 | DBMET01477 | |
| 0.038 | 0.08 | 0.183 | CD45 antagonist | 0.047 0.043 DBMET03338 0.183 0.005 DBMET01477 | DBMET01477 | |
| 0.036 | 0.077 | 0.069 | Topoisomerase II beta inhibitor | 0.069 0.017 DBMET01477 0.053 0.029 DB00122 | DBMET01477 | |
| 0.021 | 0.063 | 0.032 | Dipeptidyl peptidase II inhibitor | 0.032 0.024 DBMET01477 | DBMET01477 | |
| 0.032 | 0.075 | 0.043 | Histamine H1 receptor agonist | 0.043 0.032 DBMET01477 | DBMET01477 | |
| 0.115 | 0.159 | 0.195 | CF transmembrane conductance regulator agonist | 0.195 0.024 DBMET01477 0.134 0.109 DB00122 | DBMET01477 | |
| 0.003 | 0.047 | 0.016 | Integrin alpha5beta6 antagonist | 0.016 0.002 DBMET01477 | DBMET01477 | |
| 0.074 | 0.119 | 0.194 | Interleukin 12 antagonist | 0.098 0.057 DBMET03338 0.194 0.006 DBMET01477 | DBMET01477 | |
| 0.049 | 0.095 | 0.142 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.142 0.021 DBMET01477 0.09 0.043 DB00122 | DBMET01477 | |
| 0.012 | 0.058 | 0.062 | Leukotriene B4 receptor 2 antagonist | 0.062 0.004 DBMET01477 | DBMET01477 | |
| 0.055 | 0.101 | 0.143 | Macrophage migration inhibitory factor inhibitor | 0.143 0.017 DBMET01477 | DBMET01477 | |
| 0.003 | 0.049 | 0.02 | Integrin alphaVbeta5 antagonist | 0.02 0.004 DBMET01477 | DBMET01477 | |
| 0.196 | 0.242 | 0.217 | Analgesic | 0.217 0.216 DB00122 | DB00122 | |
| 0.005 | 0.051 | 0.012 | Free fatty acid receptor 2 antagonist | 0.012 0.004 DBMET01477 | DBMET01477 | |
| 0.046 | 0.092 | 0.065 | Immunoglobulin Fc receptor antagonist | 0.065 0.017 DBMET01477 0.061 0.022 DB00122 | DBMET01477 | |
| 0.041 | 0.087 | 0.092 | Angiotensin-converting enzyme inhibitor | 0.05 0.047 DBMET03338 0.092 0.01 DBMET01477 | DBMET01477 | |
| 0.013 | 0.06 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.032 0.007 DBMET01477 | DBMET01477 | |
| 0.102 | 0.149 | 0.575 | Insulin secretagoues | 0.211 0.03 DBMET03338 0.575 0.004 DBMET01477 | DBMET01477 | |
| 0.094 | 0.141 | 0.178 | Sphingosine 1-phosphate receptor 4 antagonist | 0.178 0.015 DBMET01477 0.109 0.096 DB00122 | DBMET01477 | |
| 0.018 | 0.066 | 0.048 | Methionyl aminopeptidase 1 inhibitor | 0.048 0.007 DBMET01477 | DBMET01477 | |
| 0.045 | 0.095 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | 0.078 0.019 DBMET01477 | DBMET01477 | |
| 0.005 | 0.054 | 0.097 | G-protein-coupled receptor 120 agonist | 0.097 0.003 DBMET01477 | DBMET01477 | |
| 0.107 | 0.157 | 0.141 | Neuropeptide Y1 antagonist | 0.141 0.08 DBMET01477 | DBMET01477 | |
| 0.036 | 0.086 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET01477 | DBMET01477 | |
| 0.016 | 0.067 | 0.128 | 5-Alpha-reductase inhibitor | 0.128 0.008 DBMET01477 | DBMET01477 | |
| 0.012 | 0.063 | 0.022 | Protease (Human cytomegalovirus) inhibitor | 0.022 0.016 DBMET01477 | DBMET01477 | |
| 0.038 | 0.089 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.037 DBMET01477 0.052 0.039 DB00122 | DBMET01477 | |
| 0.019 | 0.071 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.021 DBMET01477 | DBMET01477 | |
| 0.041 | 0.094 | 0.116 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 DBMET03338 0.116 0.006 DBMET01477 | DBMET01477 | |
| 0.002 | 0.056 | 0.01 | Neurokinin 3 agonist | 0.01 0.009 DBMET01477 | DBMET01477 | |
| 0.037 | 0.091 | 0.079 | Heparanase inhibitor | 0.079 0.007 DBMET01477 | DBMET01477 | |
| 0.047 | 0.102 | 0.097 | Ryanodine receptor antagonist | 0.097 0.005 DBMET01477 | DBMET01477 | |
| 0.026 | 0.081 | 0.064 | Metalloproteinase-3 inhibitor | 0.064 0.022 DBMET01477 | DBMET01477 | |
| 0.011 | 0.066 | 0.192 | Leukotriene B4 receptor 1 antagonist | 0.03 0.018 DBMET03338 0.192 0.003 DBMET01477 | DBMET01477 | |
| 0.068 | 0.124 | 0.315 | Hematopoietic | 0.089 0.051 DBMET03338 0.315 0.005 DBMET01477 | DBMET01477 | |
| 0.006 | 0.061 | 0.013 | Purine nucleoside phosphorylase inhibitor | 0.013 0.006 DBMET01477 | DBMET01477 | |
| 0.057 | 0.114 | 0.54 | Cell adhesion molecule inhibitor | 0.135 0.019 DBMET03338 0.54 0.004 DBMET01477 | DBMET01477 | |
| 0.126 | 0.183 | 0.343 | Free radical scavenger | 0.168 0.126 DBMET03338 0.343 0.04 DBMET01477 | DBMET01477 | |
| 0.034 | 0.091 | 0.076 | HCV NS3/NS4A protease inhibitor | 0.076 0.012 DBMET01477 | DBMET01477 | |
| 0.014 | 0.071 | 0.161 | Caspase 2 inhibitor | 0.03 0.023 DBMET03338 0.161 0.003 DBMET01477 | DBMET01477 | |
| 0.007 | 0.065 | 0.016 | Cyclin T1 inhibitor | 0.016 0.015 DB00122 | DB00122 | |
| 0.027 | 0.085 | 0.064 | Thymidine kinase inhibitor | 0.064 0.012 DBMET01477 0.046 0.022 DB00122 | DBMET01477 | |
| 0.094 | 0.153 | 0.138 | Neurotrophic factor | 0.138 0.071 DBMET01477 | DBMET01477 | |
| 0.061 | 0.12 | 0.13 | Caspase 7 inhibitor | 0.13 0.011 DBMET01477 | DBMET01477 | |
| 0.014 | 0.074 | 0.086 | Peroxisome proliferator-activated receptor delta agonist | 0.086 0.007 DBMET01477 | DBMET01477 | |
| 0.015 | 0.074 | 0.05 | LFA antagonist | 0.05 0.005 DBMET01477 0.025 0.024 DB00122 | DBMET01477 | |
| 0.04 | 0.101 | 0.167 | Purinergic P2X1 antagonist | 0.167 0.005 DBMET01477 0.062 0.04 DB00122 | DBMET01477 | |
| 0.01 | 0.07 | 0.101 | 5-Alpha-reductase 2 inhibitor | 0.101 0.005 DBMET01477 | DBMET01477 | |
| 0.016 | 0.077 | 0.431 | GP IIb/IIIa receptor antagonist | 0.068 0.025 DBMET03338 0.431 0.004 DBMET01477 | DBMET01477 | |
| 0.043 | 0.105 | 0.076 | Protein kinase C beta inhibitor | 0.076 0.037 DBMET01477 0.071 0.045 DB00122 | DBMET01477 | |
| 0.055 | 0.117 | 0.119 | MDM2 inhibitor | 0.119 0.004 DBMET01477 0.064 0.058 DB00122 | DBMET01477 | |
| 0.01 | 0.073 | 0.139 | Kynurenine 3 monooxygenase inhibitor | 0.139 0.003 DBMET01477 | DBMET01477 | |
| 0.053 | 0.118 | 0.223 | Keratolytic | 0.223 0.007 DBMET01477 0.087 0.041 DB00122 | DBMET01477 | |
| 0.004 | 0.07 | 0.025 | Integrin alpha4beta1 antagonist | 0.025 0.008 DBMET01477 | DBMET01477 | |
| 0.064 | 0.129 | 0.094 | mTOR complex 2 inhibitor | 0.091 0.045 DBMET01477 0.094 0.041 DB00122 | DB00122 | |
| 0.032 | 0.098 | 0.212 | Selectin antagonist | 0.062 0.048 DBMET03338 0.212 0.01 DBMET01477 | DBMET01477 | |
| 0.035 | 0.102 | 0.09 | Sphingosine 1-phosphate receptor 3 antagonist | 0.09 0.011 DBMET01477 | DBMET01477 | |
| 0.033 | 0.101 | 0.054 | Heme oxygenase inhibitor | 0.054 0.009 DBMET01477 | DBMET01477 | |
| 0.079 | 0.147 | 0.144 | Factor V inhibitor | 0.095 0.082 DBMET03338 0.144 0.021 DBMET01477 | DBMET01477 | |
| 0.007 | 0.075 | 0.032 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.032 0.007 DBMET01477 | DBMET01477 | |
| 0.006 | 0.075 | 0.083 | 5-Alpha-reductase 1 inhibitor | 0.083 0.005 DBMET01477 | DBMET01477 | |
| 0.07 | 0.139 | 0.141 | Proteasome inhibitor | 0.141 0.052 DBMET01477 | DBMET01477 | |
| 0.007 | 0.077 | 0.062 | Cholecystokinin agonist | 0.062 0.005 DBMET01477 | DBMET01477 | |
| 0.072 | 0.144 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.032 DBMET01477 0.087 0.085 DB00122 | DBMET01477 | |
| 0.058 | 0.13 | 0.359 | Alcohol dehydrogenase inhibitor | 0.09 0.065 DBMET03338 0.359 0.004 DBMET01477 0.087 0.068 DB00122 | DBMET01477 | |
| 0.018 | 0.091 | 0.052 | Inosine monophosphate dehydrogenase inhibitor | 0.052 0.014 DBMET01477 | DBMET01477 | |
| 0.007 | 0.08 | 0.039 | Cholecystokinin A agonist | 0.039 0.005 DBMET01477 | DBMET01477 | |
| 0.018 | 0.093 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 DBMET01477 0.028 0.014 DB00122 | DBMET01477 | |
| 0.051 | 0.126 | 0.109 | Peroxisome proliferator-activated receptor gamma antagonist | 0.109 0.012 DBMET01477 | DBMET01477 | |
| 0.011 | 0.087 | 0.09 | Prostaglandin EP4 antagonist | 0.09 0.005 DBMET01477 | DBMET01477 | |
| 0.059 | 0.135 | 0.141 | Falcipain 3 inhibitor | 0.141 0.041 DBMET01477 0.108 0.063 DB00122 | DBMET01477 | |
| 0.012 | 0.089 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.017 | 0.095 | 0.028 | Complement factor 1s inhibitor | 0.028 0.01 DBMET01477 | DBMET01477 | |
| 0.004 | 0.083 | 0.062 | Peroxisome proliferator-activated receptor alpha antagonist | 0.062 0.007 DBMET01477 | DBMET01477 | |
| 0.027 | 0.106 | 0.12 | Maillard reaction inhibitor | 0.12 0.01 DBMET01477 | DBMET01477 | |
| 0.055 | 0.135 | 0.115 | Protease inhibitor | 0.115 0.051 DBMET01477 | DBMET01477 | |
| 0.014 | 0.097 | 0.069 | Farnesoid X receptor agonist | 0.069 0.007 DBMET01477 | DBMET01477 | |
| 0.05 | 0.132 | 0.068 | Calcium channel P-type blocker | 0.068 0.032 DBMET01477 0.063 0.046 DB00122 | DBMET01477 | |
| 0.067 | 0.15 | 0.119 | Protein kinase C gamma inhibitor | 0.119 0.054 DBMET01477 0.099 0.079 DB00122 | DBMET01477 | |
| 0.022 | 0.105 | 0.061 | Tryptophan 5 hydroxylase inhibitor | 0.061 0.004 DBMET01477 | DBMET01477 | |
| 0.012 | 0.096 | 0.069 | G protein-coupled receptor agonist | 0.069 0.01 DBMET01477 | DBMET01477 | |
| 0.015 | 0.099 | 0.124 | ATP citrate lysase inhibitor | 0.124 0.003 DBMET01477 | DBMET01477 | |
| 0.036 | 0.119 | 0.094 | Fibroblast growth factor 2 antagonist | 0.094 0.027 DB00122 | DB00122 | |
| 0.055 | 0.138 | 0.258 | HIV-1 integrase (Overall Integration) inhibitor | 0.258 0.005 DBMET01477 0.092 0.062 DB00122 | DBMET01477 | |
| 0.013 | 0.097 | 0.088 | Free fatty acid receptor 1 antagonist | 0.088 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.095 | 0.055 | Liver X receptor beta antagonist | 0.055 0.007 DBMET01477 | DBMET01477 | |
| 0.047 | 0.132 | 0.084 | Adrenaline agonist | 0.084 0.052 DBMET01477 0.078 0.06 DB00122 | DBMET01477 | |
| 0.026 | 0.113 | 0.099 | Neutrophil collagenase inhibitor | 0.099 0.022 DBMET01477 | DBMET01477 | |
| 0.152 | 0.24 | 0.238 | Calpain 2 inhibitor | 0.238 0.158 DBMET01477 | DBMET01477 | |
| 0.027 | 0.115 | 0.139 | NMDA receptor glycine site agonist | 0.139 0.005 DBMET01477 0.087 0.024 DB00122 | DBMET01477 | |
| 0.018 | 0.107 | 0.084 | Phosphorylase inhibitor | 0.084 0.016 DBMET01477 | DBMET01477 | |
| 0.047 | 0.136 | 0.206 | Monophenol monooxygenase inhibitor | 0.206 0.032 DBMET01477 | DBMET01477 | |
| 0.023 | 0.112 | 0.069 | Nerve growth factor antagonist | 0.069 0.005 DBMET01477 | DBMET01477 | |
| 0.03 | 0.121 | 0.085 | Androgen agonist | 0.085 0.021 DBMET01477 | DBMET01477 | |
| 0.011 | 0.102 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.028 0.005 DBMET01477 0.021 0.015 DB00122 | DBMET01477 | |
| 0.065 | 0.157 | 0.155 | Beta amyloid protein antagonist | 0.155 0.037 DBMET01477 | DBMET01477 | |
| 0.029 | 0.121 | 0.042 | CF transmembrane conductance regulator antagonist | 0.042 0.02 DB00122 | DB00122 | |
| 0.013 | 0.106 | 0.04 | Diamine oxidase inhibitor | 0.04 0.024 DB00122 | DB00122 | |
| 0.083 | 0.177 | 0.358 | Anticoagulant | 0.154 0.076 DBMET03338 0.358 0.02 DBMET01477 | DBMET01477 | |
| 0.024 | 0.118 | 0.145 | NMDA 2C receptor antagonist | 0.145 0.007 DBMET01477 | DBMET01477 | |
| 0.003 | 0.097 | 0.02 | Angiotensin AT1B receptor antagonist | 0.02 0.006 DBMET01477 | DBMET01477 | |
| 0.043 | 0.137 | 0.073 | Beta 3 adrenoreceptor antagonist | 0.073 0.03 DBMET01477 0.064 0.046 DB00122 | DBMET01477 | |
| 0.017 | 0.112 | 0.038 | Factor XIIIa inhibitor | 0.038 0.025 DBMET01477 | DBMET01477 | |
| 0.069 | 0.164 | 0.132 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET01477 0.118 0.1 DB00122 | DBMET01477 | |
| 0.017 | 0.112 | 0.096 | NMDA 2A receptor antagonist | 0.096 0.014 DBMET01477 | DBMET01477 | |
| 0.027 | 0.123 | 0.07 | Matrix metalloproteinase (membrane-type) inhibitor | 0.07 0.025 DBMET01477 | DBMET01477 | |
| 0.077 | 0.174 | 0.176 | Interleukin 4 antagonist | 0.176 0.032 DBMET01477 | DBMET01477 | |
| 0.023 | 0.12 | 0.052 | Cannabinoid CB1 receptor agonist | 0.052 0.051 DB00122 | DB00122 | |
| 0.1 | 0.198 | 0.204 | Sphingosine 1-phosphate receptor 5 antagonist | 0.204 0.01 DBMET01477 0.144 0.072 DB00122 | DBMET01477 | |
| 0.004 | 0.102 | 0.018 | Integrin beta2 antagonist | 0.018 0.005 DBMET01477 | DBMET01477 | |
| 0.009 | 0.109 | 0.022 | Geranylgeranyltransferase inhibitor | 0.022 0.016 DBMET01477 | DBMET01477 | |
| 0.016 | 0.116 | 0.048 | Angiotensin II receptor antagonist | 0.048 0.008 DBMET01477 | DBMET01477 | |
| 0.01 | 0.11 | 0.118 | Kainate receptor 2 antagonist | 0.118 0.004 DBMET01477 | DBMET01477 | |
| 0.055 | 0.156 | 0.098 | Topoisomerase II inhibitor | 0.095 0.092 DBMET01477 0.098 0.088 DB00122 | DB00122 | |
| 0.029 | 0.131 | 0.124 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.124 0.011 DBMET01477 | DBMET01477 | |
| 0.018 | 0.12 | 0.042 | Potassium channel Kv1.3 blocker | 0.042 0.039 DBMET01477 | DBMET01477 | |
| 0.025 | 0.127 | 0.058 | Vanilloid 3 antagonist | 0.058 0.005 DBMET01477 | DBMET01477 | |
| 0.059 | 0.162 | 0.157 | GABA receptor agonist | 0.157 0.032 DBMET01477 | DBMET01477 | |
| 0.051 | 0.155 | 0.126 | Sphingosine 1-phosphate receptor antagonist | 0.126 0.011 DBMET01477 | DBMET01477 | |
| 0.02 | 0.126 | 0.123 | AMPA 4 receptor antagonist | 0.123 0.004 DBMET01477 | DBMET01477 | |
| 0.017 | 0.123 | 0.058 | Angiotensin AT1 receptor antagonist | 0.058 0.008 DBMET01477 | DBMET01477 | |
| 0.058 | 0.165 | 0.113 | Nitric-oxide synthase inhibitor | 0.113 0.043 DBMET01477 | DBMET01477 | |
| 0.013 | 0.121 | 0.041 | Cholesterol ester transfer protein antagonist | 0.041 0.012 DBMET01477 | DBMET01477 | |
| 0.009 | 0.117 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET01477 0.024 0.023 DB00122 | DBMET01477 | |
| 0.059 | 0.168 | 0.161 | Xanthine oxidase inhibitor | 0.161 0.03 DBMET01477 | DBMET01477 | |
| 0.013 | 0.122 | 0.044 | Carbonic anhydrase VII inhibitor | 0.044 0.036 DBMET01477 | DBMET01477 | |
| 0.035 | 0.146 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | 0.075 0.056 DBMET01477 | DBMET01477 | |
| 0.016 | 0.127 | 0.033 | Histone deacetylase 7 inhibitor | 0.033 0.03 DBMET01477 | DBMET01477 | |
| 0.001 | 0.113 | 0.011 | Mannitol 2-dehydrogenase inhibitor | 0.011 0.004 DB00122 | DB00122 | |
| 0.068 | 0.18 | 0.109 | Cytokine production inhibitor | 0.109 0.101 DBMET01477 | DBMET01477 | |
| 0.072 | 0.185 | 0.542 | Cell adhesion inhibitor | 0.171 0.035 DBMET03338 0.542 0.004 DBMET01477 | DBMET01477 | |
| 0.032 | 0.148 | 0.427 | Sphingosine 1-phosphate receptor 5 agonist | 0.069 0.017 DBMET03338 0.427 0.003 DBMET01477 | DBMET01477 | |
| 0.028 | 0.146 | 0.083 | Matrix metalloproteinase inhibitor | 0.083 0.035 DBMET01477 | DBMET01477 | |
| 0.083 | 0.204 | 0.244 | Mannose-6-phosphate isomerase inhibitor | 0.244 0.013 DBMET01477 0.184 0.04 DB00122 | DBMET01477 | |
| 0.069 | 0.19 | 0.143 | NADPH oxidase inhibitor | 0.143 0.059 DBMET01477 | DBMET01477 | |
| 0.129 | 0.251 | 0.243 | Transcription factor STAT3 inhibitor | 0.243 0.089 DBMET01477 | DBMET01477 | |
| 0.039 | 0.162 | 0.15 | NMDA receptor antagonist | 0.15 0.024 DBMET01477 | DBMET01477 | |
| 0.061 | 0.186 | 0.098 | CC chemokine 5 receptor agonist | 0.098 0.024 DBMET01477 | DBMET01477 | |
| 0.004 | 0.128 | 0.08 | Neutral endopeptidase inhibitor | 0.08 0.005 DBMET01477 | DBMET01477 | |
| 0.012 | 0.137 | 0.027 | ICAM 1 antagonist | 0.027 0.009 DBMET01477 | DBMET01477 | |
| 0.008 | 0.134 | 0.27 | Prostacyclin antagonist | 0.032 0.023 DBMET03338 0.27 0.003 DBMET01477 | DBMET01477 | |
| 0.031 | 0.156 | 0.074 | Sphingosine kinase inhibitor | 0.074 0.02 DBMET01477 0.071 0.024 DB00122 | DBMET01477 | |
| 0.022 | 0.15 | 0.05 | GABA receptor antagonist | 0.05 0.045 DBMET01477 | DBMET01477 | |
| 0.028 | 0.157 | 0.069 | Sphingosine kinase 2 inhibitor | 0.063 0.029 DBMET01477 0.069 0.022 DB00122 | DB00122 | |
| 0.057 | 0.187 | 0.12 | D-Ala-D-Ala ligase inhibitor | 0.12 0.013 DBMET01477 0.079 0.073 DB00122 | DBMET01477 | |
| 0.036 | 0.169 | 0.12 | Metalloproteinase-2 inhibitor | 0.12 0.029 DBMET01477 | DBMET01477 | |
| 0.008 | 0.142 | 0.043 | HCV NS5B polymerase inhibitor | 0.043 0.012 DBMET01477 | DBMET01477 | |
| 0.009 | 0.143 | 0.122 | Kainate receptor antagonist | 0.122 0.005 DBMET01477 | DBMET01477 | |
| 0.015 | 0.151 | 0.057 | RNA-directed RNA polymerase inhibitor | 0.057 0.01 DBMET01477 | DBMET01477 | |
| 0.042 | 0.179 | 0.114 | Urease inhibitor | 0.114 0.051 DBMET01477 | DBMET01477 | |
| 0.019 | 0.156 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 DBMET01477 | DBMET01477 | |
| 0.028 | 0.166 | 0.06 | Fatty acid synthase inhibitor | 0.06 0.036 DBMET01477 | DBMET01477 | |
| 0.061 | 0.199 | 0.106 | T cell inhibitor | 0.106 0.02 DBMET01477 | DBMET01477 | |
| 0.017 | 0.155 | 0.046 | Bromodomain-containing protein 3 inhibitor | 0.046 0.039 DB00122 | DB00122 | |
| 0.008 | 0.146 | 0.074 | AMPA 3 receptor antagonist | 0.074 0.005 DBMET01477 | DBMET01477 | |
| 0.003 | 0.142 | 0.029 | Egl nine homolog 1 inhibitor | 0.029 0.004 DBMET01477 | DBMET01477 | |
| 0.01 | 0.148 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DBMET01477 | DBMET01477 | |
| 0.01 | 0.149 | 0.076 | Nicotinic acid receptor agonist | 0.076 0.007 DBMET01477 | DBMET01477 | |
| 0.007 | 0.147 | 0.205 | Leukotriene D4 antagonist | 0.205 0.004 DBMET01477 | DBMET01477 | |
| 0.024 | 0.164 | 0.075 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.075 0.018 DBMET01477 0.049 0.044 DB00122 | DBMET01477 | |
| 0.058 | 0.198 | 0.179 | Nav1.4 sodium channel blocker | 0.097 0.08 DBMET03338 0.179 0.024 DBMET01477 | DBMET01477 | |
| 0.005 | 0.145 | 0.387 | Integrin beta3 antagonist | 0.387 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.151 | 0.046 | DNA gyrase subunit B inhibitor | 0.046 0.017 DBMET01477 | DBMET01477 | |
| 0.003 | 0.145 | 0.077 | Kainate receptor 1 antagonist | 0.077 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.154 | 0.047 | Carbonic anhydrase I inhibitor | 0.047 0.046 DBMET01477 | DBMET01477 | |
| 0.078 | 0.221 | 0.231 | Farnesoid X receptor antagonist | 0.231 0.014 DBMET01477 | DBMET01477 | |
| 0.003 | 0.146 | 0.019 | Egl nine homolog 3 inhibitor | 0.019 0.004 DBMET01477 | DBMET01477 | |
| 0.013 | 0.157 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.015 DBMET01477 0.026 0.019 DB00122 | DBMET01477 | |
| 0.047 | 0.192 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 DBMET01477 | DBMET01477 | |
| 0.005 | 0.15 | 0.099 | Thyroid hormone alpha antagonist | 0.099 0.004 DBMET01477 | DBMET01477 | |
| 0.036 | 0.182 | 0.09 | Metalloproteinase-9 inhibitor | 0.09 0.038 DBMET01477 | DBMET01477 | |
| 0.023 | 0.169 | 0.145 | VCAM-1 antagonist | 0.038 0.033 DBMET03338 0.145 0.004 DBMET01477 | DBMET01477 | |
| 0.01 | 0.156 | 0.045 | Retinoid X gamma receptor antagonist | 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.005 | 0.151 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.028 0.005 DBMET01477 | DBMET01477 | |
| 0.023 | 0.17 | 0.147 | VCAM antagonist | 0.038 0.033 DBMET03338 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.024 | 0.171 | 0.151 | Glucagon-like peptide 1 receptor antagonist | 0.151 0.004 DBMET01477 | DBMET01477 | |
| 0.074 | 0.222 | 0.129 | Transcription factor STAT6 inhibitor | 0.129 0.045 DBMET01477 | DBMET01477 | |
| 0.016 | 0.163 | 0.059 | Glutamate (mGluR1) antagonist | 0.059 0.04 DBMET01477 | DBMET01477 | |
| 0.049 | 0.197 | 0.126 | 5 Hydroxytryptamine 3A agonist | 0.126 0.051 DBMET01477 | DBMET01477 | |
| 0.014 | 0.164 | 0.469 | Prostaglandin EP2 antagonist | 0.076 0.029 DBMET03338 0.469 0.003 DBMET01477 | DBMET01477 | |
| 0.018 | 0.168 | 0.048 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DBMET01477 0.048 0.019 DB00122 | DB00122 | |
| 0.058 | 0.208 | 0.46 | Thrombolytic | 0.182 0.061 DBMET03338 0.46 0.007 DBMET01477 | DBMET01477 | |
| 0.005 | 0.156 | 0.091 | Cholecystokinin B antagonist | 0.091 0.005 DBMET01477 | DBMET01477 | |
| 0.017 | 0.169 | 0.097 | Glutamate (mGluR4) agonist | 0.097 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.163 | 0.122 | NMDA receptor subunit 3A antagonist | 0.122 0.007 DBMET01477 | DBMET01477 | |
| 0.006 | 0.161 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET01477 | DBMET01477 | |
| 0.006 | 0.161 | 0.102 | Retinoid X gamma receptor agonist | 0.102 0.004 DBMET01477 | DBMET01477 | |
| 0.027 | 0.182 | 0.071 | Botulinum neurotoxin type A inhibitor | 0.071 0.024 DBMET01477 | DBMET01477 | |
| 0.047 | 0.202 | 0.315 | Chelator | 0.095 0.085 DBMET03338 0.315 0.01 DBMET01477 | DBMET01477 | |
| 0.012 | 0.169 | 0.041 | Alpha 1d adrenoreceptor agonist | 0.041 0.025 DBMET01477 | DBMET01477 | |
| 0.02 | 0.177 | 0.103 | Glutamate (mGluR8) antagonist | 0.036 0.024 DBMET03338 0.103 0.003 DBMET01477 | DBMET01477 | |
| 0.022 | 0.18 | 0.085 | Collagenase 3 inhibitor | 0.085 0.021 DBMET01477 | DBMET01477 | |
| 0.017 | 0.176 | 0.058 | Dihydroorotase inhibitor | 0.058 0.017 DBMET01477 | DBMET01477 | |
| 0.009 | 0.169 | 0.654 | Integrin antagonist | 0.044 0.029 DBMET03338 0.654 0.004 DBMET01477 | DBMET01477 | |
| 0.105 | 0.265 | 0.186 | 5 Hydroxytryptamine 1E antagonist | 0.186 0.147 DBMET01477 | DBMET01477 | |
| 0.006 | 0.166 | 0.1 | Retinoid X beta receptor agonist | 0.1 0.003 DBMET01477 | DBMET01477 | |
| 0.004 | 0.165 | 0.074 | AMPA 1 receptor antagonist | 0.074 0.008 DBMET01477 | DBMET01477 | |
| 0.006 | 0.168 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.029 0.018 DBMET01477 | DBMET01477 | |
| 0.038 | 0.201 | 0.118 | Inducible nitric-oxide synthase inhibitor | 0.118 0.026 DBMET01477 | DBMET01477 | |
| 0.054 | 0.218 | 0.118 | Alkaline phosphatase inhibitor | 0.118 0.089 DBMET01477 0.109 0.101 DB00122 | DBMET01477 | |
| 0.02 | 0.186 | 0.128 | Glucagon-like peptide 1 agonist | 0.128 0.012 DBMET01477 | DBMET01477 | |
| 0.007 | 0.173 | 0.037 | Integrin beta6 antagonist | 0.014 0.011 DBMET03338 0.037 0.002 DBMET01477 | DBMET01477 | |
| 0.007 | 0.176 | 0.092 | Complement C3a chemotactic receptor antagonist | 0.092 0.01 DBMET01477 | DBMET01477 | |
| 0.019 | 0.188 | 0.155 | Glutamate (mGluR group III) agonist | 0.155 0.005 DBMET01477 | DBMET01477 | |
| 0.169 | 0.338 | 0.406 | Calcium channel L-type activator | 0.406 0.077 DBMET01477 0.288 0.168 DB00122 | DBMET01477 | |
| 0.015 | 0.187 | 0.146 | NMDA receptor subunit 3B antagonist | 0.146 0.006 DBMET01477 | DBMET01477 | |
| 0.086 | 0.262 | 0.172 | Pregnane X receptor agonist | 0.172 0.025 DBMET01477 | DBMET01477 | |
| 0.013 | 0.192 | 0.051 | Collagenase inhibitor | 0.051 0.031 DBMET01477 | DBMET01477 | |
| 0.024 | 0.204 | 0.052 | Glucose-6-phosphate translocase inhibitor | 0.052 0.035 DBMET01477 | DBMET01477 | |
| 0.004 | 0.185 | 0.271 | Integrin alpha4 antagonist | 0.271 0.004 DBMET01477 | DBMET01477 | |
| 0.012 | 0.193 | 0.134 | Integrin alpha5beta1 antagonist | 0.134 0.005 DBMET01477 | DBMET01477 | |
| 0.006 | 0.189 | 0.083 | Glucagon receptor antagonist | 0.083 0.005 DBMET01477 | DBMET01477 | |
| 0.014 | 0.197 | 0.069 | Retinoic acid alpha receptor agonist | 0.069 0.006 DBMET01477 | DBMET01477 | |
| 0.006 | 0.19 | 0.149 | Integrin beta5 antagonist | 0.149 0.004 DBMET01477 | DBMET01477 | |
| 0.022 | 0.207 | 0.217 | Leukotriene synthesis inhibitor | 0.217 0.005 DBMET01477 | DBMET01477 | |
| 0.039 | 0.227 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET01477 | DBMET01477 | |
| 0.033 | 0.221 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 DBMET01477 | DBMET01477 | |
| 0.005 | 0.194 | 0.149 | Cholecystokinin antagonist | 0.149 0.005 DBMET01477 | DBMET01477 | |
| 0.016 | 0.205 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 DBMET01477 | DBMET01477 | |
| 0.027 | 0.216 | 0.081 | Dihydroorotate oxidase inhibitor | 0.081 0.01 DBMET01477 | DBMET01477 | |
| 0.005 | 0.196 | 0.27 | Vitronectin receptor antagonist | 0.27 0.003 DBMET01477 | DBMET01477 | |
| 0.009 | 0.201 | 0.051 | Glutamate (mGluR group II) antagonist | 0.051 0.015 DBMET01477 | DBMET01477 | |
| 0.083 | 0.276 | 0.17 | 3C-like protease (Human coronavirus) inhibitor | 0.17 0.074 DBMET01477 | DBMET01477 | |
| 0.004 | 0.198 | 0.035 | NMDA receptor glycine site antagonist | 0.035 0.01 DBMET01477 | DBMET01477 | |
| 0.075 | 0.271 | 0.19 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.19 0.106 DBMET01477 | DBMET01477 | |
| 0.008 | 0.206 | 0.033 | Liver X receptor beta agonist | 0.033 0.023 DBMET01477 | DBMET01477 | |
| 0.015 | 0.214 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 DBMET01477 | DBMET01477 | |
| 0.032 | 0.231 | 0.091 | Myeloperoxidase inhibitor | 0.091 0.047 DBMET01477 0.085 0.058 DB00122 | DBMET01477 | |
| 0.005 | 0.207 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.024 DBMET01477 | DBMET01477 | |
| 0.013 | 0.216 | 0.074 | Xanthine dehydrogenase inhibitor | 0.074 0.029 DBMET01477 | DBMET01477 | |
| 0.004 | 0.208 | 0.097 | Purinergic P2T antagonist | 0.097 0.005 DBMET01477 | DBMET01477 | |
| 0.006 | 0.213 | 0.102 | Urate transporter 1 inhibitor | 0.102 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.215 | 0.027 | CXC chemokine 2 receptor antagonist | 0.027 0.018 DBMET01477 | DBMET01477 | |
| 0.004 | 0.215 | 0.367 | Prostaglandin D2 antagonist | 0.367 0.003 DBMET01477 | DBMET01477 | |
| 0.011 | 0.222 | 0.257 | Macrophage elastase inhibitor | 0.257 0.004 DBMET01477 | DBMET01477 | |
| 0.156 | 0.367 | 0.278 | MAP kinase 1 inhibitor | 0.278 0.204 DB00122 | DB00122 | |
| 0.014 | 0.225 | 0.07 | Erythropoietin receptor agonist | 0.07 0.014 DBMET01477 | DBMET01477 | |
| 0.024 | 0.239 | 0.101 | Androgen antagonist | 0.101 0.046 DBMET01477 | DBMET01477 | |
| 0.032 | 0.251 | 0.069 | Adenosine A3 receptor antagonist | 0.069 0.06 DBMET01477 | DBMET01477 | |
| 0.014 | 0.235 | 0.352 | Plasminogen activator inhibitor antagonist | 0.352 0.003 DBMET01477 | DBMET01477 | |
| 0.014 | 0.238 | 0.049 | MAP3K5 inhibitor | 0.049 0.013 DBMET01477 | DBMET01477 | |
| 0.005 | 0.229 | 0.037 | Thyroid hormone alpha agonist | 0.037 0.004 DBMET01477 | DBMET01477 | |
| 0.02 | 0.249 | 0.062 | Aldosterone antagonist | 0.062 0.018 DBMET01477 | DBMET01477 | |
| 0.02 | 0.249 | 0.05 | Potassium channel (ATP-sensitive) activator | 0.05 0.03 DBMET01477 | DBMET01477 | |
| 0.021 | 0.253 | 0.053 | Potassium channel (Inward rectifier) activator | 0.053 0.031 DBMET01477 | DBMET01477 | |
| 0.005 | 0.239 | 0.095 | Sphingosine 1-phosphate receptor 3 agonist | 0.095 0.007 DBMET01477 | DBMET01477 | |
| 0.05 | 0.285 | 0.113 | Estrogen antagonist | 0.113 0.068 DBMET01477 | DBMET01477 | |
| 0.011 | 0.246 | 0.058 | Caspase 6 inhibitor | 0.058 0.004 DBMET01477 | DBMET01477 | |
| 0.01 | 0.245 | 0.244 | Peroxisome proliferator-activated receptor delta antagonist | 0.244 0.004 DBMET01477 | DBMET01477 | |
| 0.021 | 0.258 | 0.096 | Integrin alpha1beta1 antagonist | 0.037 0.029 DBMET03338 0.096 0.003 DBMET01477 | DBMET01477 | |
| 0.006 | 0.243 | 0.196 | Integrin alphaVbeta3 antagonist | 0.196 0.003 DBMET01477 | DBMET01477 | |
| 0.099 | 0.338 | 0.238 | Transcription factor STAT inhibitor | 0.238 0.095 DBMET01477 | DBMET01477 | |
| 0.095 | 0.336 | 0.261 | Hypoxia-inducible factor 1 alpha inhibitor | 0.261 0.091 DBMET01477 | DBMET01477 | |
| 0.018 | 0.261 | 0.081 | Aminopeptidase microsomal inhibitor | 0.081 0.024 DBMET01477 | DBMET01477 | |
| 0.022 | 0.267 | 0.061 | CXC chemokine 1 receptor antagonist | 0.061 0.021 DBMET01477 | DBMET01477 | |
| 0.038 | 0.285 | 0.102 | Beta glucuronidase inhibitor | 0.102 0.067 DBMET01477 | DBMET01477 | |
| 0.044 | 0.29 | 0.095 | Interleukin 5 antagonist | 0.095 0.047 DBMET01477 | DBMET01477 | |
| 0.062 | 0.311 | 0.203 | Nitric oxide antagonist | 0.203 0.066 DBMET01477 | DBMET01477 | |
| 0.004 | 0.255 | 0.019 | Angiotensin-converting enzyme 2 inhibitor | 0.019 0.01 DBMET01477 | DBMET01477 | |
| 0.136 | 0.388 | 0.765 | Cyclophilin D inhibitor | 0.384 0.1 DBMET03338 0.765 0.009 DBMET01477 | DBMET01477 | |
| 0.018 | 0.271 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.03 DBMET01477 | DBMET01477 | |
| 0.012 | 0.266 | 0.061 | Aminopeptidase N inhibitor | 0.061 0.024 DBMET01477 | DBMET01477 | |
| 0.004 | 0.26 | 0.112 | Cholecystokinin A antagonist | 0.112 0.007 DBMET01477 | DBMET01477 | |
| 0.035 | 0.295 | 0.157 | AMP-activated protein kinase stimulant | 0.157 0.024 DBMET01477 | DBMET01477 | |
| 0.009 | 0.269 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.021 DBMET01477 | DBMET01477 | |
| 0.037 | 0.303 | 0.117 | MAP kinase kinase 1 inhibitor | 0.083 0.081 DBMET01477 0.117 0.038 DB00122 | DB00122 | |
| 0.005 | 0.272 | 0.073 | AMPA receptor antagonist | 0.073 0.02 DBMET01477 | DBMET01477 | |
| 0.043 | 0.314 | 0.185 | ABCA1 expression enhancer | 0.185 0.011 DBMET01477 | DBMET01477 | |
| 0.003 | 0.277 | 0.348 | Free fatty acid receptor 1 agonist | 0.348 0.003 DBMET01477 | DBMET01477 | |
| 0.008 | 0.282 | 0.045 | Glutamate (mGluR group I) agonist | 0.045 0.036 DBMET01477 | DBMET01477 | |
| 0.012 | 0.29 | 0.069 | p53 inhibitor | 0.069 0.005 DBMET01477 | DBMET01477 | |
| 0.034 | 0.311 | 0.158 | Histone deacetylase class III inhibitor | 0.158 0.038 DBMET01477 | DBMET01477 | |
| 0.076 | 0.353 | 0.224 | Thyroid hormone antagonist | 0.224 0.142 DBMET01477 | DBMET01477 | |
| 0.033 | 0.312 | 0.13 | Cyclooxygenase 1 inhibitor | 0.13 0.071 DBMET01477 | DBMET01477 | |
| 0.006 | 0.292 | 0.139 | Integrin alphaVbeta1 antagonist | 0.139 0.003 DBMET01477 | DBMET01477 | |
| 0.055 | 0.342 | 0.208 | Hexokinase inhibitor | 0.208 0.031 DBMET01477 0.123 0.114 DB00122 | DBMET01477 | |
| 0.073 | 0.359 | 0.198 | Thyroid hormone beta antagonist | 0.198 0.155 DBMET01477 | DBMET01477 | |
| 0.004 | 0.294 | 0.037 | Kainate receptor 3 antagonist | 0.037 0.005 DBMET01477 | DBMET01477 | |
| 0.011 | 0.308 | 0.074 | Neuraminidase inhibitor | 0.074 0.03 DBMET01477 | DBMET01477 | |
| 0.079 | 0.38 | 0.188 | Histone acetyltransferase inhibitor | 0.188 0.087 DBMET01477 | DBMET01477 | |
| 0.038 | 0.343 | 0.275 | Pyruvate kinase inhibitor | 0.275 0.054 DBMET01477 | DBMET01477 | |
| 0.024 | 0.33 | 0.091 | Protein kinase C zeta inhibitor | 0.091 0.064 DBMET01477 | DBMET01477 | |
| 0.017 | 0.327 | 0.075 | Guanylate cyclase stimulant | 0.075 0.01 DBMET01477 | DBMET01477 | |
| 0.01 | 0.323 | 0.078 | Endothelin-converting enzyme inhibitor | 0.078 0.018 DBMET01477 | DBMET01477 | |
| 0.003 | 0.318 | 0.08 | Integrin alpha4beta7 antagonist | 0.08 0.004 DBMET01477 | DBMET01477 | |
| 0.02 | 0.341 | 0.073 | Secretase beta inhibitor | 0.073 0.045 DBMET01477 | DBMET01477 | |
| 0.003 | 0.328 | 0.085 | Integrin beta7 antagonist | 0.085 0.004 DBMET01477 | DBMET01477 | |
| 0.026 | 0.352 | 0.057 | Cathepsin E inhibitor | 0.057 0.044 DBMET01477 | DBMET01477 | |
| 0.028 | 0.358 | 0.13 | Aminoacyl-tRNA synthetase inhibitor | 0.13 0.025 DBMET01477 | DBMET01477 | |
| 0.005 | 0.341 | 0.084 | NMDA 2 receptor antagonist | 0.084 0.041 DBMET01477 | DBMET01477 | |
| 0.039 | 0.377 | 0.163 | MAP kinase kinase 2 inhibitor | 0.138 0.132 DBMET01477 0.163 0.109 DB00122 | DB00122 | |
| 0.004 | 0.343 | 0.203 | Prostaglandin EP3 antagonist | 0.203 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.351 | 0.037 | Estrogen-related receptor beta antagonist | 0.037 0.014 DB00122 | DB00122 | |
| 0.058 | 0.402 | 0.131 | MAP kinase 3 inhibitor | 0.131 0.104 DBMET01477 | DBMET01477 | |
| 0.02 | 0.364 | 0.13 | HIV-1 integrase inhibitor | 0.13 0.012 DBMET01477 | DBMET01477 | |
| 0.006 | 0.354 | 0.027 | Retinoic acid beta receptor agonist | 0.027 0.006 DBMET01477 | DBMET01477 | |
| 0.027 | 0.375 | 0.105 | Chymotrypsin inhibitor | 0.105 0.033 DBMET01477 | DBMET01477 | |
| 0.027 | 0.384 | 0.378 | Protein-tyrosine phosphatase inhibitor | 0.378 0.01 DBMET01477 | DBMET01477 | |
| 0.007 | 0.369 | 0.6 | Prostaglandin antagonist | 0.6 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.376 | 0.091 | Protein kinase (CK2) inhibitor | 0.091 0.072 DBMET01477 | DBMET01477 | |
| 0.008 | 0.376 | 0.078 | Prostaglandin-E synthase inhibitor | 0.078 0.04 DBMET01477 | DBMET01477 | |
| 0.011 | 0.38 | 0.115 | Protein kinase (CK2) alpha inhibitor | 0.115 0.066 DBMET01477 | DBMET01477 | |
| 0.017 | 0.388 | 0.068 | Transcription factor AP-1 inhibitor | 0.068 0.033 DBMET01477 | DBMET01477 | |
| 0.013 | 0.386 | 0.177 | CDC25A inhibitor | 0.177 0.009 DBMET01477 | DBMET01477 | |
| 0.006 | 0.385 | 0.03 | Retinoic acid gamma receptor agonist | 0.03 0.006 DBMET01477 | DBMET01477 | |
| 0.008 | 0.389 | 0.113 | HIV-1 integrase (Strand Transfer) inhibitor | 0.113 0.018 DBMET01477 | DBMET01477 | |
| 0.006 | 0.395 | 0.23 | Aldose reductase inhibitor | 0.23 0.006 DBMET01477 | DBMET01477 | |
| 0.011 | 0.403 | 0.302 | Protein-tyrosine phosphatase 1B inhibitor | 0.302 0.01 DBMET01477 | DBMET01477 | |
| 0.003 | 0.405 | 0.147 | VLA-4 antagonist | 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.015 | 0.427 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 DBMET01477 | DBMET01477 | |
| 0.008 | 0.421 | 0.122 | Glutamate receptor agonist | 0.122 0.026 DBMET01477 | DBMET01477 | |
| 0.003 | 0.418 | 0.027 | Retinoic acid alpha receptor antagonist | 0.027 0.008 DBMET01477 | DBMET01477 | |
| 0.003 | 0.432 | 0.031 | Endothelin B receptor antagonist | 0.031 0.009 DBMET01477 | DBMET01477 | |
| 0.005 | 0.455 | 0.088 | Protocollagen prolyl hydroxylase inhibitor | 0.088 0.004 DBMET01477 | DBMET01477 | |
| 0.018 | 0.476 | 0.064 | Carbonic anhydrase II stimulant | 0.064 0.019 DBMET01477 | DBMET01477 | |
| 0.004 | 0.475 | 0.056 | Kainate receptor 4 antagonist | 0.056 0.006 DBMET01477 | DBMET01477 | |
| 0.003 | 0.476 | 0.024 | Retinoic acid receptor antagonist | 0.024 0.008 DBMET01477 | DBMET01477 | |
| 0.004 | 0.482 | 0.065 | Endothelin receptor antagonist | 0.065 0.008 DBMET01477 | DBMET01477 | |
| 0.003 | 0.488 | 0.036 | Endothelin A receptor antagonist | 0.036 0.009 DBMET01477 | DBMET01477 | |
| 0.006 | 0.492 | 0.105 | HIV-1 integrase (3'-Processing) inhibitor | 0.105 0.024 DBMET01477 | DBMET01477 | |
| 0.012 | 0.505 | 0.06 | Aggrecanase 1 inhibitor | 0.06 0.009 DBMET01477 | DBMET01477 | |
| 0.009 | 0.506 | 0.172 | 5-Lipoxygenase inhibitor | 0.172 0.031 DBMET01477 | DBMET01477 | |
| 0.018 | 0.529 | 0.042 | Parathyroid hormone antagonist | 0.042 0.041 DBMET01477 | DBMET01477 | |
| 0.013 | 0.528 | 0.039 | HCV polyprotein inhibitor | 0.039 0.013 DBMET01477 | DBMET01477 | |
| 0.006 | 0.526 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.53 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DBMET01477 | DBMET01477 | |
| 0.003 | 0.54 | 0.067 | Prostaglandin EP1 antagonist | 0.067 0.005 DBMET01477 | DBMET01477 | |
| 0.003 | 0.556 | 0.057 | Kainate receptor 5 antagonist | 0.057 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.566 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.016 DBMET01477 | DBMET01477 | |
| 0.022 | 0.589 | 0.151 | Amyloid beta precursor protein antagonist | 0.151 0.101 DBMET01477 | DBMET01477 | |
| 0.018 | 0.589 | 0.111 | DNA helicase inhibitor | 0.111 0.004 DBMET01477 | DBMET01477 | |
| 0.003 | 0.598 | 0.013 | Integrin alphaLbeta2 antagonist | 0.013 0.01 DBMET01477 | DBMET01477 | |
| 0.005 | 0.607 | 0.032 | Liver X receptor antagonist | 0.032 0.02 DBMET01477 | DBMET01477 | |
| 0.014 | 0.622 | 0.231 | Dual specificity phosphatase 3 inhibitor | 0.231 0.047 DBMET01477 | DBMET01477 | |
| 0.004 | 0.612 | 0.13 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.13 0.005 DBMET01477 | DBMET01477 | |
| 0.006 | 0.618 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.023 DBMET01477 | DBMET01477 | |
| 0.023 | 0.639 | 0.179 | Histone deacetylase SIRT1 inhibitor | 0.179 0.04 DBMET01477 | DBMET01477 | |
| 0.016 | 0.634 | 0.263 | Dual specificity phosphatase inhibitor | 0.263 0.035 DBMET01477 | DBMET01477 | |
| 0.062 | 0.682 | 0.181 | MAP kinase kinase 5 inhibitor | 0.181 0.06 DB00122 | DB00122 | |
| 0.004 | 0.654 | 0.208 | Prostaglandin E2 antagonist | 0.208 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.668 | 0.066 | NMDA 2D receptor antagonist | 0.066 0.005 DBMET01477 | DBMET01477 | |
| 0.006 | 0.683 | 0.094 | CDC25B inhibitor | 0.094 0.018 DBMET01477 | DBMET01477 | |
| 0.004 | 0.696 | 0.095 | AMPA 2 receptor antagonist | 0.095 0.005 DBMET01477 | DBMET01477 | |
| 0.004 | 0.701 | 0.04 | AMPA receptor agonist | 0.04 0.018 DBMET01477 | DBMET01477 | |
| 0.041 | 0.765 | 0.131 | Sphingosine 1-phosphate receptor 2 agonist | 0.131 0.04 DB00122 | DB00122 | |
| 0.006 | 0.744 | 0.143 | Mcl-1 antagonist | 0.143 0.097 DBMET01477 | DBMET01477 | |
| 0.017 | 0.758 | 0.258 | Antiobesity | 0.258 0.149 DBMET01477 | DBMET01477 | |
| 0.033 | 0.791 | 0.288 | Caspase 3 stimulant | 0.288 0.085 DBMET01477 | DBMET01477 | |
| 0.007 | 0.79 | 0.252 | Uric acid excretion stimulant | 0.252 0.007 DBMET01477 | DBMET01477 | |
| 0.005 | 0.892 | 0.166 | M17 leucyl aminopeptidase inhibitor | 0.166 0.047 DBMET01477 | DBMET01477 | |
| 0.019 | 0.962 | 0.186 | NOS3 expression enhancer | 0.186 0.047 DBMET01477 | DBMET01477 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |